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Bai, Yunfeng, Ph.D., Purdue University, May 2015. Functional Study of Mammary 
Epithelial Cell Architecture. Major Professor: Sophie Lelièvre. 
Cell organization confers cellular identity and guides cellular functions. Here, the cell 
organization is defined as the global arrangement of the functional complexes, which are 
composed of proteins, nucleic acids, lipids, or the combinations of any of them, in the 
cells. These functional complexes are arranged in a spatial and temporal manner, which 
closely reflects and regulates cellular activities.Targeting two proteins that act as central 
nodes in the nucleus, the nuclear mitotic apparatus protein, NuMA, and in the cytoplasm, 
the CDP-diacylglycerol synthase 1, CDS1, I have studied their influences on two features 
of the cell architecture, namely the nucleolus and the polarity axis, that play a major role 
in the homeostasis of mammary epithelial cells and in cancerous development.  The 
nucleolus is an essential nuclear body with functions in ribosome biosynthesis, stress 
perception, and cell cycle control. Basoapical polarity is the signature structure of the 
differentiated epithelial cells and is functionally related to cell proliferation and survival.  
By modulating the expression of NuMA or of CDS1 and assessing the resulting impact 
on the nucleolus or the tissue polarity axis, respectively, my goal was to further the 
understanding of the regulation and role of these architectural features in cell phenotypes. 
I have shown in my major project that NuMA is involved in the control of nucleolar 
architecture and rDNA transcription. I also showed in my minor project that CDS1 
partially restores basal polarity depending on signaling in aggressive MDA-MB-213 
cancer cells. I have placed these studies focused on cellular architecture in the context of 





CHAPTER 1: INTRODUCTION 
1.1.   Primary prevention of breast cancer 
According to the estimation from the American Cancer Society (American Cancer 
Society Inc., 2014), about 232,670 new cases of invasive breast cancer and 62,570 extra 
cases of in situ breast cancer will be diagnosed in American women in 2014. Among the 
patients diagnosed in 2014, approximately 40,000 will die from breast cancer that same 
year. Worldwide, about 1.67 million new cases of breast cancer were predicted in 2012 
and half-a-million of lives were to be lost 
(http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx). Considering these diagnosed 
patients are mothers, wives, daughters, and sisters, millions of people’s lives have been or 
will be greatly affected not only physically but also psychologically and economically. 
Beyond the physical and psychological suffering, which is difficult to quantify, the 
estimated global economic loss from breast cancer was $88 billion in 2008, representing 
0.15% of the world’s gross domestic product of that year (American Cancer Society and 
LIVESTRONG, 2010). This economic loss does not even include the direct medical cost 
of the treatment of breast cancer.  
As a devastating disease it still is, our society already has accomplished great 
strides during the long fight with breast cancer. Statistical data from the National Center 




mortality from breast cancer has steadily decreased annually by 1.8% in white, 1.6% in 
African American, 1.7% in Hispanics, and 1% in Asians/Pacific Islanders during 2001-
2010 in the United States; it is unchanged in American Indians/Alaska Natives (American 
Cancer Society Inc., 2014). The dropdown of the mortality is attributed to improved 
treatment and widely applied screening. The overall breast cancer incidence has kept 
increasing until remained stable since 2004 in the USA, but unfortunately, the rising 
trend is not changed in most developing countries 
(http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx). With no doubt, decreased 
mortality is partially due to the improved treatment as well as cancer screening that have 
attracted most funding resources. Treatment and screening are exclusively dealing with 
tumors already formed in the patients’ body; therefore, these efforts could not affect 
breast cancer incidence, and the same large number of people still have to suffer from the 
disease. Primary prevention is the only way to reduce the incidence and the great damage 
from the disease because it is targeting the reduction of breast cancer occurrence. 
Is breast cancer preventable and if so, how? Although the underlying mechanisms 
of cancer initiation remain largely unknown, existing evidence strongly supports the idea 
that breast cancer can be prevented to some extent. Studies on native Asians or Asian-
Americans (Ziegler, Hoover et al. 1993) have connected the substantial increased risk of 
breast cancer with the adoption of western lifestyles. The results clearly suggested that 
the potential risk factors encompass more than the long-known genetic predisposition and 
carcinogens. Encouragingly for primary prevention research, these lifestyle-related risk 




risk factors have been identified and are categorized as non-modifiable factors (gender, 
age, personal and family history of breast cancer, and personal physical conditions) and 
modifiable factors including both lifestyle-related factors (postmenopausal hormone use, 
obesity, physical activity, diet, alcohol, tobacco, and oral contraceptive use) and other 
factors (exposure to radiation, specific chemicals, environmental pollution, and specific 
occupations).  More detailed studies about the relative risk for each factor have been 
reviewed (Colditz and Bohlke 2014). It should be noted that primary prevention 
strategies can be designed for application not only to modifiable risk factors but also to 
some non-modifiable factors. For example, a study showed that treatment with 
Tamoxifen reduced the risk of Estrogen Receptor positive (ER+) invasive and in situ 
breast cancer by 42% in women with family history of breast cancer, and thus considered 
at increased risk for breast cancer (Fisher, Costantino et al. 1998).  Prophylactic 
mastectomy is also considered as a particular primary prevention strategy for women 
with genetic BRCA1 or BRCA2 mutation. Ideally, the strategies of primary prevention 
should be simple, painless, and less expensive than detection and treatment. With an 
enhanced understanding of the risk factors in the future, personalized design of primary 
prevention strategies is expected to play an increasingly important role in the battle 
against breast cancer. 
Yet, one awkward situation that the primary prevention of breast cancer field has 
to face is that most essential but non-modifiable risk factors, such as aging, being female, 
and family history of breast cancer, seem to be unpreventable at present. Furthermore, for 




efficacy can be only expected in populations rather than the individual cases. These 
issues are actually addressing the same fundamental aspect of the current state of primary 
prevention research, i.e. our large knowledge gap between the risks and true cancer 
occurrence. Rome wasn’t built in a day, so wasn’t the aggressive cancer. A series of 
errors and abnormal activities have to accumulate to transit a normal cell into a cancer 
cell and logically, these mistakes should be accompanied with morphological alterations 
occurring at different levels during tumorigenesis. Cancer is a disease arising from cells 
that have lost proliferation control. Therefore, understanding the molecular and cellular 
activities that promote cell proliferation and the related morphological changes at 
molecular, cellular, and tissue levels will help filling the knowledge gap between risk and 
cancer initiation.  In addition, characterization of the morphological abnormalities of the 
cells and tissue in pre-cancer and progression stages will also benefit early diagnosis of 
breast cancer. The mostly applied method for breast cancer screening at present is 
mammography, which enables the detection of tumor at median size 1.0 – 1.5 cm (Guth, 
Huang et al. 2008).  Better characterization of pathological alterations in early stage 
cancer nodules will improve the accuracy of cancer diagnosis and provide valuable 
information for the appropriate treatments of these small tumors.  
To achieve these goals we need a better understanding of the cell architecture. 
The concept of cell architecture here is defined as the characteristic arrangement of 
cellular complexes based on their function cell-wide under normal physiological 
condition.  The cellular functional complexes can be any entities, comprising proteins, 




displaying a distinct ‘geographic’ pattern in a spatial and temporal manner. To be more 
specific, mammary epithelial cells in the normal breast tissue always display a typical 
architecture conveyed by cell polarity and nuclear organization, which defines their 
identity and functions to be different from other types of cells (Lelievre 2010; Grafton, 
Wang et al. 2011).  
1.2.   Mammary epithelial polarity as a cell quiescence controlling machinery 
It is a well-accepted rule that structure determines function in the inorganic world 
as well as in organic chemistry; however, in living organisms, this rule is compromised 
by the evolution.  In fact, after long-term natural selection over random genetic 
mutations, the relationship between structure and function in modern organisms is 
accustomed to the mode of mutual adaptation. The interdependent nature of structure and 
function in the body allows for any change on one side to influence the other side, which 
can be evidenced by the diseased organs, tissues, and cells in the body. 
Human breast consists of mammary glands, where breast cancer occurs, 
surrounded by fatty and connective tissues. The mammary gland is a highly organized 
tissue composed of two basic units, namely the acinus and the duct. The acinus is a 
sphere-like structure with a single continuous layer of luminal epithelial cells that secrete 
milk proteins during the lactation period and a discontinuous layer of myoepithelial cells 
lining the luminal cells against the stroma to expel milk into the duct. Through a small 
duct called terminal duct, several acini are connected to larger ducts branched to other 




grapes. There are about 8-15 of such ductal systems or lobes in each breast that each open 
via an enlarged duct at the nipple.  
Depending on where the lesion grows, breast epithelial proliferative diseases are 
mainly classified into two types, lobular and ductal.  Based on whether the basement 
membrane is infiltrated or not, breast epithelial proliferative diseases are categorized as 
pre-invasive and invasive stages. Accordingly, the morphological characteristics for each 
type of lesion have been well documented and are used for clinical diagnosis. But as 
mentioned above, the earlier the disease stage, the less we know. Hyperplasia is 
considered to happen prior to carcinoma in situ, both of which are pre-invasive stages.  
Histological analysis of hyperplasias has revealed that there is a disruption of normal 
mammary gland architecture. The most prominent change is the replacement of the single 
layer of luminal epithelium by a multilayered epithelium due to the increased number of 
cells in the lumen. Studies also suggested a slight increase of risk of invasive carcinoma 
from both usual hyperplasia and atypical hyperplasia (Elston and Ellis 1991).  
It is not known how hyperplasia initiates, yet a clear clue is that the lesion sites 
contain more cells than in normal conditions, which likely implies somewhat of a  loss of 
proliferation control in a portion of the cell populations. With the exception of pregnancy 
and lactation, most mammary epithelial cells maintain quiescence. The resting normal 
epithelium displays the unique tissue architecture, namely basal-apical polarity. It is 
defined by the location of tight junctions (TJ) at the apical side of cell-cell contacts 
against the lumen, while at the basal side exemplified by cell-extracellular matrix 




functions in anchorage and signal exchange between cells and their surrounding 
extracellular matrix. Impaired basal polarity will induce cell anoikis (Eble and Haier 
2006). The classical function for apical polarity is to block the diffusion of small 
molecules, such as proteins and fat, along the cell membrane of luminal cells (Krug, 
Schulzke et al. 2014). But lately studies also uncovered its role in cell homeostasis 
maintenance and proliferation control. 
Tight junctions seal two adjacent epithelial cells at the apical pole through the 
interaction of three transmembrane proteins claudins, occludins, and junctional adhesion 
molecule (JAM) produced by each neighboring cell. The appropriate localization, 
assembly, and function of TJ are supported by many other interacting protein complexes 
under the cell membrane and, together, they are referred as the apical junctional complex 
(AJP) (Lelievre 2010). Currently identified members that regulate TJ formation are 
Crumbs3/Pals-1/PATJ complex, PAR-6/PAR-3/aPKC/Cdc42 complex, and 
Scrib/DLg/Lgl. Zonula Ocluden (ZO)-1/ ZO-2/ZO-3 proteins that provide the scaffold of 
TJ and mediate the connection of TJ to cytoskeletal F-actin. More information on AJP 
regulators and their functions can be found in a recent review (Van Itallie and Anderson 
2014). 
Studies in Drosophila indicate that tight junctions form after adherens junctions 
(Lelievre 2010). Unfortunately the tight junction feature is difficult to reproduce in cell 
culture. Among numerous human mammary epithelial cell lines that still maintain 
adherens junctions as well as basal polarity, the non-neoplastic HMT-3522 S1 cell line is 




for tight junction markers ZO-1, ZO-2, Par3, and Pasl-1 under three dimensional (3D) 
cell culture conditions (Plachot, Chaboub et al. 2009). It seems that the architecture of 
apical polarity is extremely sensitive to environmental/cell functional changes compared 
to lateral and basal structures of polarity. Indeed, the fragility of apical polarity is 
understandable given the involvement of the ever-increasing number of proteins 
identified at the APJ. Accordingly, it is not surprising to witness the profound influence 
that the disruption of apical polarity has on cellular activities when the interactions 
among different APJ proteins go awry.  Work from our laboratory has demonstrated that 
acini produced in 3D culture to display impaired apical polarity contain cells primed to 
enter the cell cycle, as indicated by the expression of the cell cycle marker Ki67 upon 
stimulation, compared to cells contained in acini with intact apical polarity 
(Chandramouly, Abad et al. 2007). We have hypothesized that apical polarity is a barrier 
for functionally differentiated mammary epithelial cells to enter the cell cycle upon 
environmental stimuli. The effect of apical polarity loss to facilitate proliferation could be 
caused by different mechanisms. The intact AJP is an apparatus composed of proteins 
important for transcription activity, epigenetic modification, and signal transduction 
(Gonzalez-Mariscal, Dominguez-Calderon et al. 2014). Thus, the presence of apical 
polarity possibly acts as a symbol of functional balance among various signaling 
pathways. 
The functional complexity of apical polarity is further evidenced by a microarray 
study on acini produced in 3D culture with apical polarity disrupted through two different 




changes upon apical polarity disruption has been identified, with genes belonging to 
distinct groups based on their functions including transcription factors, epigenetic 
modifiers, and signal transducers. Of particularly interest, a gene CDS1 involved in lipid 
metabolism was also identified (Cardenas JM, Ph.D. Thesis, 2012).  
1.3.   Lipid metabolism in cancer cells and the potential influence on polarity 
CDS1 was identified in our earlier work to be down-regulated upon the disruption 
of apical polarity in a 3D cell culture model mimicking the differentiated mammary 
epithelium. Its protein product is the cytidine diphosphate-diacylglycerol (CDP-DAG) 
synthetase 1 responsible for the production of phosphatidylinositols (PI) from 
phosphatidic acid (PA) (Lykidis, Jackson et al. 1997).  The CDP-DAG pathway 
possesses a unique position and essential functions in the whole lipid metabolism 
network. The de novo synthesis of PA, the upstream substrate of CDS1, uses glucose-6-
phosphate and fatty acid (FA) as substrates; thus it connects the glycolysis pathway and 
the FA synthesis pathway (Baenke, Peck et al. 2013). The CDP-DAG pathway also 
generates PI, phosphatidylglycerol (PG), and cardiolipin downstream products, 
suggesting that it mediates multiple biological functions. By all means, CDS1 should be 
an ideal example to study the influence of the metabolism, especially lipid metabolism, 
on tissue architecture and cancer development.     
Deregulated cellular metabolism in cancer cells has gained more and more 
attention in recent years thanks to the implementation of several high throughput 
techniques, like chromatin immunoprecipitation followed by sequencing (ChIP-seq) and 




supporting rapid cell proliferation, energetic metabolism reprogramming has been 
considered as an emerging hallmark of cancer (Hanahan and Weinberg 2011). Perhaps 
the most seminal observation linking metabolism to cancer is the “Warburg effect” 
proposed in 1920s and revealing that glucose is mainly consumed in a low-ATP-
generating way, namely aerobic glycolysis, in cancer cells compared to the much more 
efficient oxidative phosphorylation in differentiated cells (Warburg 1956; Gatenby and 
Gillies 2004). Noteworthy, the switch to aerobic glycolysis was also discovered in some 
types of non-neoplastic proliferating cells in recent studies (Vander Heiden, Cantley et al. 
2009). The reason for cancer cells metabolizing glucose primarily through aerobic 
glycolysis remains elusive, but it is believed to generate more intermediates to meet the 
needs for the synthesis of macromolecules, like nucleic acid and lipids, in rapidly 
dividing cells. The cause-or-consequence debate regarding altered metabolism in cancer 
development lasted until the identification of cancer-associated metabolic enzymes that 
include tumor suppressor genes fumarate hydratase (FH), succinate dehydrogenase 
(SDH), and oncogene isocitrate dehydrogenase (IDH) (Losman and Kaelin 2013), as well 
as the most recent finding of histone deacetylase SIRT6 that controls cancerous 
metabolism activation (Sebastian, Zwaans et al. 2012). These studies have strongly 
supported the driver role of dysfunctional metabolism in tumorigenesis.  
Together with major glucose metabolic pathways switched to aerobic glycolysis 
in cancer, de novo fatty acid (FA) biosynthesis is also recognized in many cancer tissues 
as the hallmark of dysfunctional lipid metabolism (Menendez and Lupu 2007). In healthy 




novo FA biosynthesis shuts down or is only maintained at basal level because cell fatty 
acids are mostly acquired from the bloodstream; however, such biosynthesis is 
reactivated in many cancer cells even if enough circulating FAs are present in the 
microenvironment (Menendez and Lupu 2007). Again, the reason for FA metabolism 
network redirection is arguably to meet the dividing demands from cancer cells, but that 
is apparently not the only explanation (Hopperton, Duncan et al. 2014).  
Lipids refer to a large group of compounds with diverse structures; roughly, they 
can be considered as the collection of fatty acids, their derivatives and substances related 
biosynthetically or functionally to these compounds. Fatty acids are naturally synthesized 
via condensation of malonyl coenzyme A units by a fatty acid synthase complex. They 
usually contain even numbers of carbon atoms in straight chains (commonly C14 to C24), 
and may be saturated or unsaturated; they can also contain other substituent groups (the 
AOCS lipid library, http://lipidlibrary.aocs.org/Lipids/whatlip/index.htm). The large 
variety of functions for lipids (membrane constituents, signaling molecules, energy 
storage components, etc.) raises the question of how they influence cancer development. 
To address this question, I would like to first review some specific FAs known to be 
associated with breast cancer occurrence; then move to the regulatory proteins and 
enzymes important for cancer formation in de novo FAs biogenesis pathway; and, at last, 
I will discuss current knowledge about the potential link between lipid metabolism and 
mammary polarity. 
Epidemiological data have connected higher breast cancer incidence to higher 




unveiled a very interesting pattern between global geographical distribution of higher 
breast cancer incidence and local diet spectrum regarding the FA types. Namely, foods 
with higher ω-3 FAs are preferred in the eastern world with lower breast cancer 
incidence, while high incidence-associated ω-6 FAs enriched diet is prevalent in the 
western world (Cardenas, JM. Ph.D. Thesis, 2012). The different risk effects on breast 
cancer incidence from different types of FA have attracted much attention for their 
potential values in primary prevention.  In an effort to understand the preventive effect of 
FAs, especially eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), 
extensive studies have been conducted in different cancer models. While the underlying 
mechanism remains elusive, results showed that ω-3 FAs play inhibitory roles on almost 
all aspects of the hallmarks of cancer (Stephenson, Al-Taan et al. 2013). Physiologically, 
ω-3 EPA and ω-6 Arachidonic Acid (AA) are both components of structural membrane 
phospholipids, and they are also acting as the precursors for the production of eicosanoids 
mediated by cyclooxygenase (COX) or lipoxygenase (LOX) enzymes. It is believed that 
the anti-inflammatory molecules generated from EPA are less biologically active than the 
pro-inflammatory AA-derivatives (Farooqui, Horrocks et al. 2007), which could partially 
explain the tumor suppressor function of ω-3 FAs, considering that inflammation can 
promote cancer development. 
In addition to the lipids per se, some enzymes and regulatory proteins involved in 
the de novo biosynthesis of FAs are important for cancer development as well. As 
mentioned above, aerobic glycolysis and de novo FA biosynthesis are the two featured 




Aerobic glycolysis produces large amounts of pyruvate, which enters mitochondria to 
turn into citrate, and the latter is eventually transported into the cytosol and used for de 
novo FA biosynthesis. Cytosolic citrate is first converted into acetyl-CoA by ATP citrate 
lyase (ACLY) followed by carboxylation to malonyl-CoA catalyzed by acetyl-CoA 
carboxylase (ACACA). The condensation of acetyl-CoA and malonyl-CoA to produce 
the most common 16-carbon saturated FA palmitate is under the control of fatty acid 
synthase (FASN). All three enzymes have been reported to be dramatically increased in 
multiple types of cancer cells and the inhibitory treatments targeting these enzymes could 
suppress proliferation in vitro and limit tumor growth in vivo (Hatzivassiliou, Zhao et al. 
2005).  In contrast to nontransformed murine hematopoietic cells, which are resistant to 
apoptosis after ACLY is silenced, (Bauer, Hatzivassiliou et al. 2005), breast cancer cells 
with silenced ACACA undergo apoptosis, but this can be rescued by supplementation of 
palmitate in the medium (Chajes, Cambot et al. 2006). This observation undermines the 
potential for ACACA to be an anticancer drug target.  Interestingly, 
immunohistochemistry studies on different stages of breast cancer show that elevated 
expression of ACACA and FASN already appears in DCIS and LCIS (Milgraum, Witters 
et al. 1997), the earliest stages that can normally be clinically detected prior to the 
massive cell proliferation, which suggests an active rather than passive involvement of 
the activation of de novo FAs biosynthesis in early tumorigenesis.  In agreement with this 
postulate, the normal-appearing mammary gland tissues from the same patients showed 
that a limited number of cells expressing ACACA and FASN are confined to lobules and 
terminal ducts. Cancer usually initiates in terminal ducts (Milgraum, Witters et al. 1997), 




Among the three enzymes, FASN attracted most attention because it catalyzes the last 
key step of the FAs biosynthesis. In the early days, FASN was used as a predictor for the 
recurrence of breast cancer, and the expression level of FASN was positively correlated 
with poor prognosis and mortality (Kuhajda, Piantadosi et al. 1989). Ectopic expression 
of FASN in nontransformed breast epithelial cell lines, MCF10A and HBL100, 
significantly promoted cell proliferation via the activation of HER1/HER2 signaling 
cascade (Vazquez-Martin, Colomer et al. 2008), but there seems to be a positive feedback 
loop to promote mutual activation between HER1/HER2 and FASN.  Indeed, on one 
hand, it has been shown that FASN is a downstream component of HER1/HER2 (Jin, 
Yuan et al. 2010; Li, Bu et al. 2012); on the other hand, immunohistological study of 
breast lesions at different stages revealed that over-expression of FASN is already 
detected in the nonproliferative benign breast disease lesions where HER2 level is yet to 
increase (Milgraum, Witters et al. 1997).  Given the facts that inhibition of FASN induces 
cell cycle arrest and over-expression of FASN activates HER2 signaling pathway, FASN 
behaves more like a “driver” role in cancer initiation. Yet, despite a clear positive 
correlation, no evidence has been reported to support a causal effect of ACLY, ACACA, 
and FASN in cancer initiation.  
In parallel with the saturated FA (palmitate) pathway, cholesterol biogenesis 
pathway (mevalonate) is also activated in the reprogrammed lipid metabolism in cancer 
cells. The two pathways branch after citrate converts into acetyl-CoA. Mevalonate and 
palmitate pathways are respectively regulated by two transcription factors, sterol 




SREBPs bind to sterol regulatory elements in the promoter regions of many genes coding 
for the major enzymes participating in lipogenesis to mediate their transcriptions. 
Currently identified signaling pathways upstream of SREBPs including 
Pi3K/AKT/mTOR and RAS/Raf/MEK/ERK again suggest a positive correlation of 
SREBPs expression with cancer development.  
Several recent publications may shed light on the connection between the 
reprogrammed mevalonate pathway in cancer cells and the disruption of cell polarity. 
The mutation of tumor suppressor gene TP53 is frequently seen in breast cancer. In most 
cases, p53 mutation occurs in concert with the elevation of the mevalonate pathway. 
Using a 3D cell culture system, the Prives group studied mammary gland morphogenesis 
under the influence of p53. They showed that over-expressing mutant p53 in 
nonmalignant MCF10A cells impaired lumen-like formation, and depletion of 
endogenously mutated p53 in the metastatic breast cancer cell line MDA-MB-468 could 
restore some architectural characteristics of in vivo mammary acini in 3D cell spheroids, 
including lumen-like formation as well as the basolateral polarity indicated by 
cytoskeleton actin and basally localized α6β4 integrins. Interestingly, the mevalonate 
pathway is the major pathway down-regulated upon the depletion of mutant p53 in 
reverted MDA-MB-468, and the reverted phenotype can be compromised by 
supplementation of upstream metabolites in the culture medium (Freed-Pastor, Mizuno et 
al. 2012).   Although it has been shown before that p53 suppresses SREBP as a 
transcription factor (Yahagi, Shimano et al. 2003), this study is the first one to link the 




provide evidence regarding the reestablishment of apical polarity in the reverted cells as 
no information on tight junctions was given.   
In many cancerous diseases, sustained activation of the Hippo signaling pathway 
promotes cell growth and proliferation, while it inhibits differentiation and apoptosis. 
Upon activation, its downstream effectors YAP/TAZ relocate from the cytoplasm to the 
cell nucleus where they function as transcriptional factors.  Recent screening in breast 
cancer cell line MDA-MB-231 uncovered that YAP/TAZ nuclear translocation can be 
abolished by pharmaceutical inhibition of the mevalonate synthesis pathway suggesting a 
regulatory role of this pathway on the Hippo pathway (Sorrentino, Ruggeri et al. 2014).  
Surprisingly, numerous apical polarity-related proteins were identified to control the 
cytoplasmic compartmentalization of YAP/TAZ. The relevant proteins include Crb 1-3, 
Frmd6, NF2, Kibra, aPKC, PAR3, PAR6, PALS1, Scrib, Dlg, Lgl, AMOT, PEPN14, 
Ajuba/LIMD1/WTIP, α-catenin, β-catenin, ZO-1, ZO-2, and E-cadherin (Yu and Guan 
2013).  Given that shutting down the mevalonate pathway can inhibit the Hippo pathway 
by sequestering YAP/TAZ in the cytoplasm and also restore tissue architecture (at least 
basolateral polarity (Freed-Pastor, Mizuno et al. 2012), an emerging hypothesis that the 
mevalonate pathway activates the Hippo pathway by disrupting apical polarity might be 
formulated.  
1.4.    The nuclear bodies in cell nuclear organization 
In addition to the polarity of the epithelium, another cellular architecture closely 
reflecting various cellular activities is the cell nucleus.  This notion is not new at all since 




architecture concomitant with transition to malignancy and applied such changes as 
classic criteria for cancer diagnosis, such as the increased nucleo-cytoplastic ratio and the 
number of nucleoli. The nuclear architecture of the cell is generally defined as the spatial 
and temporal arrangement of the nuclear bodies and chromatin within the nucleus. 
Nuclear bodies are highly dynamic structures raised from the nucleation and interactions 
among a large group of proteins/RNAs (Dundr and Misteli 2010). Due to the lack of lipid 
membrane outside of the nuclear bodies, the components, proteins and RNAs, exchange 
fast between the nuclear body and the surrounding environment. Yet overall, the 
nucleation, the location, and the composing elements of several types of nuclear bodies 
appear to remain stable. Thanks to the development of immunolabeling and imaging 
techniques, a number of new nuclear bodies have been identified like 53BP1 body 
involved in DNA repair (Panier and Boulton 2014) and polycomb body involved in 
transcription control (Pirrotta and Li 2012).  But even for the nuclear bodies identified 
many years ago, important information is still elusive, especially regarding structure, 
biogenesis and biological functions. Because many nuclear bodies are found temporally 
associated with or close to specific chromosome loci, one of their functions is thought to 
be protein storage for assigned chromosome activities under particular circumstances 
(Dundr and Misteli 2010).  In Table 1.4.1, I summarized current knowledge about the 
“classic” nuclear bodies including nucleolus, Cajal body, splicing factor speckles, 
Promyelocytic leukemia protein (PML) nuclear body, and perinucleolar body. The main 
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For therapeutic purpose, an attractive research field is to understand the 
biogenesis of nuclear bodies. In contrast to the assembly of cellular polarity that displays 
a hierarchical order in the recruitment of various protein complexes, current evidence 
support a stochastic self-organization model for the formation of specific nuclear bodies 
(Dundr and Misteli 2010). This model highlights the equal importance of the essential 
components of a nuclear body for its biogenesis.  The model was proposed from the study 
showing that the Cajal body can be generated de novo by nucleating a number of its 
components including proteins and RNAs (Kaiser, Intine et al. 2008).  Interestingly, the 
formation of the PML body was also observed by over-expressing a component protein 
of the PML nuclear body in the same study, suggesting that this model is not limited to 
the Cajal body. The randomness of the initiator and the recruitment process is the core 
concept of the stochastic self-organization model. Currently, the triggers in the first step 
of nucleation remain unknown for most nuclear bodies.  
1.5.    Chromatin organization and its biological functions in homeostasis 
Our knowledge about chromatin organization in the cell nucleus is greatly 
improved due to the development of high-throughput molecular biology techniques, 
especially DNA next generation sequencing, chromatin conformation capture (3C) 
(Dekker, Rippe et al. 2002), and thereafter 3C derived techniques. An amazing fact about 
our genome is that the two-meter-long chromatin string has to be packed into a cell 
nucleus with an average 10-micrometer in diameter. To efficiently respond to various 
stimuli, the chromatin must be highly organized. Chromatin organization during the 




chromatin is the well-known beads-on-a-string composed of histone octamers wrapped 
by linear DNA. The secondary chromatin organization is the 30 nanometer fiber formed 
by the interactions between neighbor nucleosomes of the primary structure. One of the 
supportive pieces of evidence came from X-ray diffraction that unraveled zigzag 
interaction among four nucleosomes with DNA strands (Schalch, Duda et al. 2005).  
Beyond the 30-nm fiber are 100-nm fiber structures and even larger fibers that are part of 
higher chromatin organization.  These chromatin fibers are very likely organized into 
loops anchored to the insoluble nuclear matrix through specific chromatin domains. This 
proposed loop organization can be visualized protruding out of the nucleus with 
application of a DNA dye after soluble nuclear proteins are removed (Roti Roti and 
Wright 1987).  DNA loops are essential structures to activate gene transcription by 
mediating the interaction between nonadjacent enhancer and promoter (Ong and Corces 
2011). In addition to these somewhat local interactions, interchromosomal and 
intrachromosomal long-distance interactions are also executed by the loop structures. For 
example, genes associated with a particular function are often activated simultaneously, 
and frequent chromatin interactions among these genes can be detected by 3C although 
some of these genes are located on different chromosomes, indicating the spatial 
proximity for these DNA loops during transcription (Schoenfelder, Sexton et al. 2010; 
Tanizawa, Iwasaki et al. 2010). The mechanism of loop generation is poorly understood, 
but current evidence suggests a tripartite involvement of chromatin binding proteins, 
specific chromatin regions and nuclear structural proteins. A group of proteins were 
identified to engage in chromatin looping including CTCF, the cohesin/codensin 




mostly studied. CTCF binds to the insulator, a DNA domain that is localized either 
between the promoter and enhancer of a gene to block their communication or at the 
boundaries of chromatin domains to demarcate the active and the repressive domains 
(Cuddapah, Jothi et al. 2009; Van Bortle and Corces 2012).  In many cases, the cohesin 
complex and CTCF co-occupy the insulator domains to coordinate transcription 
regulation (Wendt, Yoshida et al. 2008). The cohesin complex comprises SMC1, SMC3, 
RAD21, and SA2 proteins that, together, form a ring structure. By tethering two binding 
sites of cohesin on the same chromosome, the cohesin ring generates a chromatin loop 
structure. The interchromosomal interaction will be engaged if the binding sites are on 
two chromosomes. A fraction of cohesin binding on the genome is independent of CTCF. 
Instead of repressing gene transcription, these cohesin complexes interact with mediator 
at the promoter regions to initiate transcription (Kagey, Newman et al. 2010). Thus, 
cohesin seems to be the key factor for chromatin looping per se but it is not responsible 
for determining the activity of the target genes, which is likely controlled by cohesin 
binding partners as well as the cohesin binding regions. Earlier studies have suggested 
that the anchorage of the matrix attachment regions (MARs) on the nuclear matrix is the 
structural basis for chromatin looping (Mirkovitch, Mirault et al. 1984; Heng, Goetze et 
al. 2004).  MARs are AT-rich domains, yet they have no consensus sequence and are 
dispersed throughout the genome with a localization propensity at gene boundaries (Loc 
and Stratling 1988; Levy-Wilson and Fortier 1989) or near regulatory elements (Cockerill 
and Garrard 1986; Gasser and Laemmli 1986). Nuclear matrix is a putative dynamic 
nuclear skeleton structure formed by insoluble nuclear proteins to support the whole 




of CTCF/cohesin with the nuclear matrix as well as the overlap of their binding regions 
with MARs (Nabirochkin, Ossokina et al. 1998; Hakimi, Bochar et al. 2002; Dunn, Zhao 
et al. 2003; Yusufzai and Felsenfeld 2004) have indicated the indispensable role of 
nuclear matrix proteins in chromatin looping.  The binding of MARs onto the nuclear 
matrix is gene activity and cell type-dependent, which reflects the dynamic nature of the 
gene loci in 3D context. Consistent with this notion, particular cancer-related genes were 
shown to reposition in a breast cell line upon acquisition of malignancy (Meaburn, Gudla 
et al. 2009).  
Chromatin self-organizes into globule-like structures within every one-megabase 
interval in human cells (Dixon, Selvaraj et al. 2012; Nora, Lajoie et al. 2012), termed 
topologically associating domains (TADs), which was also seen in the fruit fly (Sexton, 
Yaffe et al. 2012) and budding yeast (Mizuguchi, Fudenberg et al. 2014) at different base 
length intervals. Very interestingly, CTCF and cohesin were respectively described to 
bind at the boundaries of TADs in human cells and budding yeast. Although only CTCF 
was reported to bind about 15% of the boundaries of TADs in human cells so far (Nora, 
Lajoie et al. 2012), it would not be surprising to see cohesin also bind to these regions at 
even higher frequency given the results in yeast. These discoveries further reinforce the 
essential role of CTCF and cohesin in global chromatin organization.  Beyond a 
megabase scale at single chromosome level, it has been shown that multiple gene-rich 
regions tend to cluster together both with fluorescence in situ hybridization (FISH) 
(Shopland, Lynch et al. 2006) and 4C (Simonis, Klous et al. 2006) techniques.  A general 




the nucleus compared to the gene-poor regions that are more often closed to the nuclear 
periphery (Branco and Pombo 2006), which raised the assumption that the periphery of 
the nucleus is less permissive for gene transcription. Indeed, this idea was reinforced by 
the observation that the transcription was decreased when a reporter gene was tethered to 
the peripheral nuclear lamina. This nuclear structure is composed of Lamin A/C and 
Lamin B that, together, form a meshwork underneath the nuclear envelope (Dechat, 
Pfleghaar et al. 2008). About 40% of the genome is associated with the nuclear lamina; 
and these genomic regions are called lamina-associated chromatin domains (LADs) 
(Guelen, Pagie et al. 2008). CTCF and cohesin are extensively occupying the chromatin 
regions adjacent to the LADs, suggesting that a large amount of loops is attached to the 
lamina. 
Genome wide, chromosomes are arranged within chromosome territories. The 
concept of chromosome territories was proposed by Boveri, T in 1909, who argued that, 
as in mitosis, chromosome retains individuality during interphase by staying in their own 
place. The model of chromosome territories was supported by a series studies, and finally 
beautifully displayed in the human cell nucleus by Bolzer et al. using 3D FISH technique 
combined with multicolor-labeled probes targeting different chromosomes (Bolzer, Kreth 
et al. 2005). It demonstrated unequivocally that the chromatin is not randomly arranged 
in the nucleus. It should be noted that although the majority of individual chromosome 
parts stay in the chromosome territory, it is common to detect intermingling of different 
chromosomes at the territory boundaries that are thought to be sites filled with most of 




Polymerase II transcription factories (Deng, Melnik et al. 2013).  Based on transcription 
activity, nuclear chromatin is characterized into two states, euchromatin (active) and 
heterochromatin (inactive). The geographic distribution of chromatin shares some 
similarities among different cell types, for example, heterochromatin is accumulating at 
the nuclear periphery and the nucleolar periphery upon cell differentiation. Nucleolus-
associated chromatin domains (NADs) also have been identified (Nemeth, Conesa et al. 
2010); strikingly, they are extensively overlapping with LADs. It is possible that a 
portion of heterochromatin can randomly associate to the nucleolus or the lamina. If this 
is the case, the interphase chromatin may display a divergent organization while the cells 
possess identical functions. 
Chromatin organization determines cell function and identity. Maintaining a 
particular chromatin organization is as important as specific transcription factors in 
producing induced pluripotent stem cells (Yu, Vodyanik et al. 2007). Even if the over-
expressed transcription factors displayed the same binding profile on specific promoter 
regions, the cell could not be reprogrammed into pluripotent stem cell without chromatin 
forming the correct loop structure (Wei, Gao et al. 2013; Zhang, Jiao et al. 2013). Altered 
chromatin organization is one of the remarkable features of cancer cells (Suva, Riggi et 
al. 2013). Genome-wide sequencing studies based on 3284 tumors have identified a 
quarter of a million genetic mutations spread on 20,000 protein-coding genes, but only 
about 125 mutated genes were considered to play the “driver role” in cancer initiation, 
among which, 20% functions in chromatin regulation (Vogelstein, Papadopoulos et al. 




epigenetic modifications and chromatin binding proteins, which accordingly determine 
the degree of local chromatin compaction and 3D chromatin topology, both known to 
profoundly affect gene transcription activity (Dawson and Kouzarides 2012) as well as 
genome integrity.  To this end, identification and characterization of such architectural 
proteins will fundamentally improve our knowledge of cancer and thus, its prevention. 
1.6.   The function of NuMA in chromatin organization control 
The nuclear mitotic apparatus protein (NuMA) was first recognized for its well 
defined role in stabilizing mitotic spindle during cell division (Lydersen and Pettijohn 
1980), which makes NuMA an essential protein for cell proliferation and the 
development of organisms. However, beyond mitosis, NuMA is intensively expressed in 
the interphase nucleus in multiple cell types (Abad, Lewis et al. 2007), including the 
neuron cells, years after differentiation and quiescence have occured (Silk, Holland et al. 
2009; Radulescu and Cleveland 2010), which raised the interesting postulate that NuMA 
must perform functions in the nucleus aside from mitosis.  NuMA is a large protein of 
about 240 kilo Dalton with a central coiled-coil domain. The coiled-coil domain provides 
the structural basis for protein self-polymerization, which was exemplified for many 
other proteins and protein complexes, like Lamin family members and SMC family 
members in cohesin/condensin (Herrmann and Aebi 2004; Poon and Mekhail 2011).  
Indeed, in Hela cells with NuMA transiently over-expressed, hexagon oligomers were 
formed by the self-organization of NuMA and a large amount of these oligomers 
arranged into a lattice-like structure filling the nucleus and resistant to detergent 




insolubility of a fraction of NuMA proteins and the interaction of NuMA with MARs, it 
has been proposed that NuMA is a nuclear matrix protein (Luderus, den Blaauwen et al. 
1994; Nickerson 2001).  Several NuMA interacting partners in the nucleus have been 
reported including GAS41 (Harborth, Weber et al. 2000), NOCA6 (Ko and Chin 2003), 
and PIM1 (Bhattacharya, Wang et al. 2002), but their role associated with NuMA 
remains unknown. 
Our laboratory has been long focusing on the nuclear function of NuMA after first 
observing a remarkable redistribution of NuMA in the cell nucleus upon differentiation in 
non-neoplastic mammary epithelial HMT-3522 S1 cells in 3D cell culture (Lelièvre, 
Weaver et al. 1998), which led to the assumption that the rearrangement of NuMA is 
concomitant with nuclear reorganization and tissue architecture. Consistent with this idea, 
differentially distributed NuMA was observed between non-neoplastic S1 cells and S1-
derived invasive T4-2 cancer cells (Knowles, Sudar et al. 2006; Chandramouly, Abad et 
al. 2007), the S1 cells that were seeded on different extracellular matrix materials, as well 
as the S1 cells exposed to radiation (Vidi, Chandramouly et al. 2012). In addition, NuMA 
accumulates at DNA damage spots within 30 minutes (Vidi, Liu et al. 2014). All these 
subtle redistributions of NuMA corresponding to different environmental stimuli 
suggested that, at least, a subset of NuMA is dynamic and sensitive to 
microenvironmental cues.   
As discussed earlier, the nuclear architecture comprises nuclear bodies and chromatin 
organized in a spatial and temporal manner. Interestingly, NuMA colocalization with 




Lewis et al. 2007) were both observed in the breast epithelial model. Hence, NuMA 
possibly plays a global nuclear architectural role by regulating nuclear bodies and 
chromatin organization together. The involvement of NuMA in higher order chromatin 
organization, as witnessed by the location of heterochromatin and euchromatin, was 
established (Abad, Lewis et al. 2007), but the underlying mechanism is still missing.  
Studies from our group have identified ISWI SNF2h ATPase as one of NuMA’s binding 
partners (Vidi, Liu et al. 2014), pointing out a reasonable direction for further analysis. 
given the fact that SNF2h participates in several chromatin remodeling complexes 
(CRCs) (Dirscherl and Krebs 2004) involved in different cellular functions. Following 
this clue, SNF2h-containing CRCs were assessed for their potential interactions with 
NuMA, and the B-WICH complex functioning in rDNA transcription was identified 
(Jayaraman, S. Ph.D. Thesis, 2014). Combined with several other pieces of evidence 
from our previous work indicating that NuMA might function in the nucleolus (the 
detailed discussion can be found in Chapter 2), I proposed my hypothesis that NuMA 
might control the architecture of the cell nucleolus. Consequently, the nucleolar 
architecture and function is introduced in the next section.  
1.7.   Cell Nucleolus 
“The nucleolus probably should not be considered a relatively simple organelle 
with a single function, comparable to a machine tool turning out a particular part of an 
automobile. It is not just ‘the organelle where the cell manufactures ribosomes.’ It is 
rather a structure through which materials of several different kinds are flowing, 




                                                                                              The cell nucleolus is the most prominent nuclear body because of its high 
visibility, even under the light microscope, and its documentation that can be tracked 
down to the seventeenth century, decades earlier than other nuclear bodies.  In nucleolus 
research history, two breakthrough discoveries probably are the identification of the 
nucleolar organizing region (NOR) as a fragment of the chromosome where the nucleolus 
forms, and the demonstration of the nucleolus function in ribosome biogenesis. The 
generation of nucleoli taking place on NORs was first reported by Heitz, E in 1931, and 
the link between ribosome biogenesis and nucleolus was established by Donald Brown 
and John Gurdon in 1964  (Brown and Gurdon 1964). Immediately after the discovery of 
the nucleolus function in ribosome biogenesis, Conrad Hal Waddington made the 
comment that I cited at the beginning of this section. I came across these remarks in a 
memorabilia-like review article (Pederson 2011) and I am surprised too, as much as the 
author of the article, by the accuracy of Waddington’s perspective half a century ago, as 
the advances in research on the nucleolus are showing every word of the statement to be 
true. 
Electron microscopy analysis of the nucleolus in mammals revealed a tripartite 
structure including the fibrillar center (FC), the dense fibrillar component (DFC), and the 
granular component (GC).  With some disagreement on the functions of these individual 
regions, a more commonly accepted opinion is that ribosome DNA transcription occurs 
in DFC as well as at the border of FC and DFC, while GC is the place for ribosomal RNA 




thought to lack transcription ability. Once the transcription is activated, Pol I-bound 
rDNA relocates to DFC (Raska, Shaw et al. 2006). Permeability and protein density 
analysis of the nucleolus in Xenopus oocyte showed a higher density of the dense fibrillar 
component, indicating that more proteins are present in the DFC compared to the 
granular component (Handwerger, Cordero et al. 2005). Permeability assay showed that 
GC is a sponge-like structure filled with two types of particles, protein-rich and nucleic 
acid-rich – likely reflecting its functions in rRNA processing and ribosome assembly.  
Outside the nucleolus is a heterochromatin shell. The perinucleolar 
heterochromatin in human HeLa cervix carcinoma cells (Nemeth, Conesa et al. 2010) and 
HT1080 fibrosarcoma cells (van Koningsbruggen, Gierlinski et al. 2010) has been 
isolated and sequenced. The identified chromosomal regions mainly include “satellite 
repeats, members of the zinc-finger, olfactory receptor defensin, immunoglobulin 
protein-coding gene families, transcriptionally active 5S rRNA genes and tRNA genes” 
(Nemeth and Langst 2011) accounting for 4% of the whole genome (unsequenced rDNA-
bearing short arms are not included). In addition, a fraction of centromeres (Pluta, 
Mackay et al. 1995) and telomeres were also reported as the constituents of the 
perinucleolar heterochromatin, probably due to their physical proximity to NORs on the 
acrocentric chromosomes. In every sense, the perinucleolus is a subnuclear site 
characterized as transcription-repressive environment. Interestingly, this “transcription-
unfriendly” site is found to transiently associate with many specific nuclear components 
in unusually high frequency at different cell stages, which implies some potential 




relocating to the perinucleolus is a signature of mammary epithelial cell differentiation 
(Lelievre 2009). Chromosome Xinactive remains silenced through its contact with 
perinucleolar heterochromatin in S phase (Zhang, Huynh et al. 2007).  Some nuclear 
bodies, like splicing factor speckles (Lelièvre, Weaver et al. 1998), Cajal body, PML, and 
the perinucleolar compartment, were reported to be close or in touch with the periphery 
of the nucleolus, yet the functions of these contacts are elusive.  With respect to the 
chromatin relocation to the perinucleolus, several chromatin binding proteins are thought 
to be important for the procedure, like CENPC1 (Wong, Brettingham-Moore et al. 2007)  
and CTCF (Yusufzai, Tagami et al. 2004). 
Although the nucleolus is considered as one of the nuclear bodies, it possesses a 
fundamental difference compared to others, which is that the assembly of the nucleolus 
completely depends on the specific chromosomal domains NORs.  NORs are tandem 
rDNA arrays arranged in head-to-tail coding for ribosomal RNAs. The copy number of 
rDNA and NORs varies largely among species. The human genome contains about 400 
copies of rDNA distributed over five pairs of NORs located between the satellite 
repetitive elements and the pericentromeric region on the short arms of acrocentric 
chromosomes 13, 14, 15, 21, and 22. Due to high repetition, DNA sequences of the short 
arms of these chromosomes are still not deciphered (Shaw and Mckeown 2011).  The 
large copy number of rDNA is believed to meet the requirements of ribosome biogenesis 
for protein synthesis in proliferating cells. Indeed, ribosomal RNA accounts for 60% and 
35% of total RNA synthesis respectively in yeast and dividing mammalian cells (Moss, 




no difference regarding the rRNA level compared to the strain with 110 copies except for 
increased sensitivity to DNA damage. Thus, the unusually large copy number of rDNA in 
the genome, especially the subset kept silent, is hypothesized to protect genome integrity 
rather than being used for ribosome biogenesis (Ide, Miyazaki et al. 2010).  In human 
cells, each single copy of rDNA encodes a 45S pre-rRNA precursor that contains, in 
order, 18S, 5.8S, and 28S rRNA coding regions. There are two external transcribed 
spacers (ETS) at 5’ end before 18S and 3’ end after 28S in the 45S pre-rRNA. In 
addition, the 5.8S rRNA coding region is flanked by two internal transcribed spacers 
(ITS) in the middle of 18S and 28S.  Both ETSs and ITSs are cleaved from 45S pre-
rRNA during rRNA processing to eventually generate 18S, 5.8S, and 28S rRNAs. 
Another rRNA 5S is transcribed from another genomic region by RNA polymerease III. 
Individual rDNAs are separated by the intergenic spacer (IGS). Again, IGS sequences 
and lengths are highly divergent among different species, from several kb in yeast to 
30kb in human.  IGS in mouse contains several rDNA regulatory elements including gene 
promoter, spacer promoter, and gene terminator distributed at both ends of one IGS. The 
schematic diagram of mouse rDNA and IGS is shown below.  
 
Figure 1.7.1   Diagram of mouse rDNA and IGS.  The external transcribed regions are 




frames, coding regions are represented by white hollow frames, and IGS is the blue line 
located between two rDNA genes. The locations of some regulatory elements are labeled 
on the top of the rDNA gene. This figure is modified based on the published scheme 
(McStay and Grummt 2008). 
The ribosomal DNA promoter is located -200bp to +50bp relative to the 
transcription start site (TSS) at 3’ end of IGS, and the terminator region is located at the 
end of rDNA indicated by the red bars. This region usually contains repetitive terminator 
elements numbered as T1-T10. Tsp is the spacer promoter located at about -2 kb upstream 
of TSS and its corresponding terminator T0 is immediately upstream of TSS. Tsp drives 
the transcription of intergenic spacer RNA, which mediates rDNA transcription 
repression.  Tandem repeats 1 and 2 contain large amounts of single repeats and 
transposable elements, yet their functions are still unclear (Sylvester JE 2004).  
Furthermore, it should be noted that no alignment study of IGS between mouse and 
human has been reported so far; therefore, it is not clear whether human IGS contains all 
the regulatory elements at the corresponding positions. 
The mechanism of nucleolus assembly has attracted much interest since the 
number of the nucleoli and the nucleolar morphology are the most prominent markers of 
the nuclear architecture correlated with cell proliferation activity.  It has been noticed for 
a long time that the disassembly and reassembly of the nucleolus are controlled by the 
cell cycle. The Nucleolus starts to dissemble in early prophase, during which, CDK1-
cyclin B plays an important role by phosphorylating B23. The phophorylation results in 




is released from the nucleolus and distributed on the surface of condensed chromosomes 
(Okuwaki, Tsujimoto et al. 2002; Negi and Olson 2006). But the upstream binding factor 
(UBF) and particular Pol I subunits still remains in NORs through the cell cycle.  The 
nucleolus reassembly occurs in telophase, with all the dissociated components re-
gathering on the NORs and the reactivation of transcription as well as processing of 
rRNA. Transcriptional activity of rDNA was once considered as the trigger for nucleolus 
restoration; however, the study of pseudo-NORs demonstrated that partial formation of 
the nucleolus can still happen without transcriptional activity (Prieto and McStay 2008). 
Pseudo-NORs are tandem arrays of a DNA sequence obtained from Xenopus rDNA and 
incorporated into human chromosomes. They only contain repeated enhancer elements 
and lack the rRNA coding region, hence it is transcription incapable. By using this 
model, the authors unarguably showed partial formation of the nucleoli around those 
pseudo-NORs with components similar to FC.  UBF binding to the enhancer elements 
determines the initiation of nucleolar reestablishment and other procedures are likely 
following a self-organization mechanism. Interestingly, the restoration of nucleoli in new 
daughter cells only takes place on the NORs that are actively transcribed in the mother 
cells (Roussel, Andre et al. 1996). This observation strongly suggested the inheritance of 
rDNA chromatin organization between cell generations. Epigenetic modifications on 
DNA and nucleosomes are likely responsible for the inherited rDNA organization in cells 
from one generation to next. 
In early years, scientists had noticed the structural difference between active 




microscope, which is that active rDNAs displayed the “Christmas tree” structures with 
knobs of ribonucleoproteins on the branches while silent rDNAs showed no branches at 
all (Miller and Beatty 1969). DAPI staining analysis of metaphase chromosomes revealed 
gaps in active NOR regions, indicating locally decondensed chromatin structure 
compared to the intense staining on silent NORs that is not distinguishable from 
heterochromatin.  Psoralen intercalates in DNA that is not protected by nucleosomes. 
Cross-linking assay performed on murine Friend cells showed that psoralen specifically 
induced DNA cross-linking in active NORs but not in silent NORs, which led the author 
to conclude that nucleosomes are gone from active rDNAs but still present on IGS and 
the inactive NORs  (Conconi, Widmer et al. 1989).  Despite validation of this observation 
in yeast (Merz, Hondele et al. 2008) and human cells (Zentner, Saiakhova et al. 2011), 
other studies have found the presence of histones on the active rDNA (Jones, Kawauchi 
et al. 2007). This discrepancy has not been well explained so far; it is possibly caused by 
the existence of other types of chromatin-binding histones, in addition to nucleosomes in 
rDNAs (Prior, Cantor et al. 1983), or by differences in sensitivity and threshold setup 
among different techniques. Nevertheless, DNA methylation was found to be enriched on 
the condensed inactive NORs, which indicates an important role of methylation in the 
maintenance of rDNA silencing (Stancheva, Lucchini et al. 1997).  Ribosomal DNA 
methylation usually occurs on CpGs in the promoter region and it is mediated by DNA 
methyltransferases DNMT1, DNMT3a, and DNMT3b. Very interestingly, only 
methylated rDNA chromatin (with the presence of nucleosomes), but not naked rDNA 
can be repressed in vitro, which suggests the importance of chromatin conformation 




CpG at -133 bp impairs UBF binding to the promoter in mouse cells and consequently 
prevents rDNA transcription. A link between hypomethylation of rDNA promoter and 
elevated rRNA transcription has been reported in several cancer types (Powell, Mutch et 
al. 2002; Ghoshal, Majumder et al. 2004), and a causal relationship is thus proposed. 
However, recent investigations in human prostate cancer tissues (Uemura, Zheng et al. 
2012) and breast cancer tissues (Bacalini, Pacilli et al. 2014) either failed to recapitulate a 
significant change of methylation level in rDNA promoter or revealed hypermethylation 
of promoter in tumor tissues compared to normal tissues although rRNA level is 
increased.  Even more complex, decreased rRNA level was observed upon the 
reactivation of former silent rDNA, which was mediated by knocking out 
methyltransferases or applying a methyltransferase inhibitor, like 5-Azacytidine (5-Aza) 
(Chen, Comai et al. 1998; Gagnon-Kugler, Langlois et al. 2009).  All current evidence 
concurs to a surprising conclusion that the elevation of rDNA transcription in cancer 
tissue is not necessarily correlated with rDNA methylation level, or with the number of 
active NORs. A methylation-independent control of rRNA transcription and a global-
monitoring system might exist in parallel to the canonical methylation-dependent 
mechanism. Depletion of UBF in human NIH3T3 cells did induce silencing of a subset of 
rDNA and condensation without significant changes in methylation levels after many cell 
generations (Sanij, Poortinga et al. 2008). It will be important to recapture this 
phenomenon under physiological conditions.  
Another layer of epigenetic control of rDNA activities is posttranslational histone 




Study in Arabidopsis showed that rDNA promoter demethylation mediated by 5-Aza led 
to repressive histone marks transiting into active marks. Similarly, blocking the function 
of histone deacetylase automatically resulted in the decrease of methylation level on 
rDNA (Earley, Lawrence et al. 2006).  The interdependent transition of these epigenetic 
marks is caused by the interactions and mutual recruitments among distinct epigenetic 
modification proteins.  Novel histone markers specific to rDNA are not reported so far, 
which suggests a similar epigenetic mechanism for the control of rDNA activities 
compared to the rest of chromatin.  
The recruitment of chromatin remodeling complexes to rDNA determines future 
epigenetic state and rDNA structure.  For example, rDNA silencing and condensation are 
mainly mediated by nucleolar remodeling complex (NoRC), which contains TIP5 (TTF1-
interacting protein 5) and an ATPase protein SNF2h (Strohner, Nemeth et al. 2001).  
TIP5 binds rDNA promoter and recruits HDAC1 (histone deacetylase 1) (Zhou, Santoro 
et al. 2002) as well as DNMT1/DNMT3B (DNA methyltransferase) (Zhou and Grummt 
2005) to accomplish epigenetic modifications.  Depletion of TIP5 not only abolishes 
rDNA silencing but also impairs the organization of perinucleolar heterochromatin 
including centric and pericentic repeats (Guetg, Lienemann et al. 2010).  SNF2h 
functions in sliding the nucleosomes on the chromatin to increase the accessibility for 
other proteins.  Environmental energy deprivation induced rDNA silencing is mediated 
by eNoSC containing nucleomethylin, the NAD+ -- dependent deacetylase SIRT1, and 
H3K9 methyltransferase SUV39H1. Coexistence of NoRC and eNoSC complexes that 




responsive to different stimuli. The activation of rDNA transcription is also mediated by 
different protein complexes. For instance, the ERCC6 (excision repair cross-
complementation group 6) / Pol I / histone methyltransferase G9a complex competitively 
binds rDNA promoter with NoRC (Yuan, Feng et al. 2007).  Another complex B-WICH 
also interacts with Pol I to mediate rDNA transcription. The B-WICH complex contains 
NM1 (actin and nuclear myosin 1c) / WSTF / SNF2h and NM1 plays a central role in 
stabilizing SNF2h and actin on rDNA in addition to recruiting HAT (histone 
acetyltransferase) (Sarshad, Sadeghifar et al. 2013).  Interestingly, SNF2h was found in 
both rDNA activation complex and silencing complex, which implicates its important but 
not selective role in altering local rDNA structure.  
A large number of active rDNA repeats neighboring the transcription-repressive 
perinucleolar heterochromatin in the cell nucleolus must require a highly organized 
chromatin arrangement to avoid interference between euchromatin and heterochromatin. 
Active rDNAs are located inside the nucleolus while silent rDNA arrays are at the 
periphery, closed to the perinucleolar heterochromatin (Santoro 2011). This is consistent 
with previous observation that rDNAs within the nucleolus relocate to the nucleolar 
periphery upon treatment with actinomycin D, a drug that inhibits Pol I at low 
concentration.  The localization of the proximal regions and the distal regions (relative to 
centromere) flanking NORs was also studied in the interphase nucleolus recently and the 
result clearly showed that the flanking regions are located at the periphery of the 
nucleolus with active decondensed rDNAs stretching into the center (Floutsakou, 




involvement of different proteins.  In the mouse, the terminator sequence motif (T1-T10, 
see Figure 1.7.1) is recognized by the transcription termination factor TTF-I.  In addition 
to binding to T1-T10 to terminate rDNA transcription, TTF-I also binds to spacer 
terminator T0 located upstream of the TTS functioning in transcription initiation (Langst, 
Blank et al. 1997; Langst, Becker et al. 1998).  By using 3C technique, Langst et al. 
showed high frequency of interaction between the spacer terminator (T0 region) and the 
gene terminator (T1-T10 region) indicating that a loop structure is created by tethering 
these two sites. The authors further showed that TTF-I mediates the loop by binding on 
these sites (Nemeth, Guibert et al. 2008).  Later on, the same group demonstrated that 
more terminator elements significantly improved transcription efficacy compared to less 
terminator elements within a single chromatin loop (Diermeier, Nemeth et al. 2013). Yet, 
neither study addressed the role of IGS in this TTF-I mediated rDNA loops model.  In 
contrast, based on the direct involvement of c-MYC in rDNA transcription (Shiue, 
Berkson et al. 2009), Shiue et al. identified potential matrix attachment regions (MARs) 
in IGS and proposed a c-MYC mediated r-chromatin looping model in human and rat 
(Shiue, Nematollahi-Mahani et al. 2014). This model addressed the binding between 
MYC and IGS upon transcription activation, which allows the transcribed regions to 
remain in the loops. Because MYC is not characterized as a nuclear matrix component, 
somehow it has to bridge the association of IGS and the nuclear matrix. The study did not 
clarify whether MYC attaches to the nucleolar matrix, thus it is not clear how the loops 
are anchored. In another study of the MARs in IGS, Zillner et al. showed that TIP5 
directly binds MARs through its TAM (TIP5/ARBP/MBD) domain as a component of 




organization of a large number of rDNAs under a transcription permissive environment. 
Although the cohesin complex is well known for its loop-generating role genome wide 
and a large body of evidence has confirmed cohesin in rDNA transcription and nucleolar 
organization control, its potential influence on rDNA looping architecture is not reported.  
The coordination of rapid cell division and increased nucleolar activities has been 
reported in many, if not all, types of cancers.  On one hand, the accelerated cell 
proliferation of cancer requires more ribosome production to support increased demands 
on protein synthesis. This goal can be achieved by over-expressing a variety of oncogenic 
proteins. Many oncoproteins simultaneously function in up-regulating rDNA 
transcription and promoting cell division,  for example, c-MYC directly binds rDNA 
promoter E-box to stimulate rDNA transcription (Arabi, Wu et al. 2005; Grandori, 
Gomez-Roman et al. 2005), in addition to binding other cell cycle regulatory genes 
(Bretones, Delgado et al. 2014). Activation of AKT can phosphorylate casein kinase IIα 
(CK2α) and CK2α further phosphorylates Pol I binding partner TIF-IA to initiate rDNA 
transcription (Nguyen le and Mitchell 2013). On the other hand, a sufficient number of 
ribosomes is also thought to be the prerequisite for cell cycle progression from G1 to S 
phase (Pederson 2011). The underlying mechanism is that the cell mass must reach a 
certain level prior to the division and this parameter is examined at check point in G1 
phase.  The cell mass is mainly characterized by the protein amount in a cell, which is 
further determined by the amount of ribosomes; ribosome biosynthesis is therefore 
determining cell cycle rate.  Indeed, the arrest of cell proliferation induced by impaired 




described in 1964 (Brown and Gurdon 1964) and thereafter. The nucleolus as the place 
for rDNA transcription, rRNA processing, ribosome assembly and exporting, is highly 
sensitive to a variety of external or internal deleterious stimuli that hinder ribosome 
production, via a cellular reaction termed nucleolar stress. Not surprisingly, any 
functional disruption of the nucleolus may lead to cell cycle arrest due to ribosome 
deficiency.  
Interestingly, compelling evidence has also unveiled a direct role of the nucleolus 
in cell cycle control beyond ribosome production. Proteomic analyses performed on 
purified nucleoli of human HeLa cells have identified over 700 proteins associated with 
the nucleolus (Andersen, Lyon et al. 2002; Andersen, Lam et al. 2005).  This is a large 
number of proteins identified in a single nuclear body and surprisingly, a large portion of 
them are irrelevant to ribosome biogenesis, which strongly suggests a multifunctional 
role of the nucleolus in addition to ribosome biogenesis.  Among those 700 proteins, 25 
are functionally categorized as cell cycle regulators, yet few studies have been conducted 
to elucidate their roles in the nucleolus so far.  More direct evidence came from the study 
of P53 activation mediated by nucleolar stress.   The expression of P53 remains very low 
in cells under normal condition; however, the level elevates rapidly upon nucleolar stress.  
Many ribosome subunit components including RPL5, RPL11, RPL23, PRL26, RPL37, 
RPS3, RPS7, RPS14, RPS15, RPS20, RPS25, RPS26, RPS27, RPS27L (Golomb, 
Volarevic et al. 2014), 5S RNA (Sloan, Bohnsack et al. 2013), and nucleolus-localized 
protein Arf (Weber, Taylor et al. 1999) can be released from the nucleolus upon nucleolar 




increased P53 subsequently leads to cell cycle arrest. Since so many nucleolar 
components regulate P53 in a similar manner, there is no doubt about the dual-role that 
the nucleolus plays, ribosome biogenesis and stress sensor, and both roles are tightly 
linked to the cell cycle. 
In this thesis work, I am focusing on two aspects of cellular architecture, polarity 
and nucleolar organization that are essential for cellular homeostasis to further decipher 
their role in cancer. My overarching hypothesis is that the function of both of these 
structures can be further deciphered by studying single proteins that act as nodes for the 
control of cellular homeostasis.  In the next chapter I will present work related to the 
understanding of the role of the nuclear structural protein NuMA, previously involved in 
differentiation, response to DNA damage, apoptosis and cell quiescence, in the 
architectural and functional control of the nucleolus. In another chapter, I will discuss the 
involvement of CDS1, a protein associated with Pi3K-AKT pathway regulating cell 

















2.1.   Introduction 
Nuclear architecture refers to the spatial and temporal organization of the 
chromatin and the nuclear bodies. NuMA, an organizer of higher order chromatin (Abad, 
Lewis et al. 2007) was also found to overlap with nuclear bodies like splicing speckles 
(Lelièvre, Weaver et al. 1998) and Cajal bodies (Gribbon, Dahm et al. 2002), suggesting 
a potential role for NuMA in the global control of nuclear architecture. The cell nucleolus 
is the nuclear body for rRNA production, processing, and ribosome assembly, which 
requires a complex organization. The nucleolus contains rDNA and nucleolar proteins 
and it is surrounded by a heterochromatin shell (Nemeth, Conesa et al. 2010). 
Heterochromatin domains such as centromere and pericentromere (Nemeth, Conesa et al. 
2010), specific proteins such as CTCF and Tin2 (Yusufzai and Felsenfeld 2004; 
Kaminker, Plachot et al. 2005), and particular nuclear bodies such as the Cajal body and 
splicing speckles (Lelievre, Weaver et al. 1998) were observed to be specifically 
associated with the nucleolus with an unusually high frequency during cell 
differentiation, suggesting the importance of the nucleolus-related organization in 




Mounting evidence suggests a link between NuMA and the nucleolus. Formerly, 
claims were that NuMA was absent from the nucleolus as observed by 
immunofluorescence microscopy (Gueth-Hallonet, Wang et al. 1998; Zeng 2000), yet a 
high-sensitivity nucleolar proteomic study revealed an association between NuMA and 
the nucleolus, which is consistent with our observation using soft X-ray electron 
microscopy (Lelièvre, unpublished data) as well as electron microscopy analysis of the 
nucleolus (Jayaraman, S. Ph.D. Thesis, 2014). This discrepancy can be logically 
explained by the fact that DNA density is extremely low in the nucleolar region, where it 
usually appears as a black hole when the nucleus is stained with DNA dyes, given the 
fact that NuMA is a chromatin-associated protein (Abad, Lewis et al. 2007). The B-
WICH complex containing SNF2h, WSTF, and NM1 was immunoprecipitated with 
NuMA (Jayaraman, S. Ph.D. Thesis, 2014), suggesting that NuMA might be involved in 
ribosomal DNA transcription control, considering the well-known function of the B-
WICH complex in rDNA activation (Sarshad, Sadeghifar et al. 2013).  The enrichment of 
NuMA was observed at the perinucleolus to coincide with cell differentiation (Abad, 
Lewis et al. 2007) and NuMA also accumulated at the periphery of nucleolus in response 
to RNA Polymerase I inhibition (Abad, P. M.S. Thesis, 2003). These results raised the 
possibility for NuMA to be involved in rDNA transcription control through the regulation 
of chromatin organization. Thus, in the major part of my thesis, I have studied the 
potential role of NuMA in the regulation of nucleolar architecture and rDNA 
transcription.  To elucidate the underlying mechanism of how NuMA might influence 
chromatin structure, I hypothesized that NuMA and specific chromatin-associated 




the cohesin complex and the effect of NuMA on chromatin looping were specifically 
studied. 
Our laboratory previously reported that in multicellular spheroids produced in 3D 
culture and displaying impaired apical polarity, inducing NuMA redistribution within 
nuclei pushes quiescent cells into the cell cycle (Chandramouly, Abad et al. 2007).  This 
is an interesting observation since it directly links changes in nuclear architecture to its 
potential biological consequence - the loss of cell quiescence.  Furthermore, the 
redistribution of epigenetic marks at the perinucleolus was observed when the function of 
endogenous NuMA was impaired by over-expressing its C-terminal peptide in non-
neoplastic breast epithelial S1 cells (Abad, Lewis et al. 2007), which gave rise to the 
hypothesis that the integrity of the nucleolar architecture maintained by a functional 
NuMA is necessary for cell quiescence.  Thus, among research efforts I also assessed the 
influence of NuMA on the cell cycle by assessing Ki67 cell cycle marker given its 
potential involvement in nucleolar functions and the tight correlation between nucleolus 
and cell cycle.      
2.2.   Materials and methods 
2.2.1.   Cell culture 
Non-neoplastic S1 HMT-3522 cells (human mammary epithelial cells (HMEC)) 
(Briand, Petersen et al. 1987) between passages 52 and 60, were plated at 1.75 x 106 
cells/cm2 and maintained for 10 days for propagation as monolayers in chemically 




(Invitrogen Corporation), supplemented with 0.15 IU/ml prolactin (Sigma-Aldrich), 250 
ng/ml insulin (Sigma-Aldrich), 2.6 ng/ml sodium selenite (BD Biosciences), 2.67x10-5 
ng/ml β-estradiol (Sigma-Aldrich), 0.5 ng/ml hydrocortisone (Sigma-Aldrich), 10 μg/ml 
transferrin (Sigma-Aldrich)], including 5 μg/ml epidermal growth factor (EGF; BD 
Biosciences). Malignant T4-2 HMT-3522 HMECs (Briand et al., 1996) between passages 
2 and 20 were plated at 8.75 x 105 cells/cm2 and maintained for 6 days in two-
dimensional (2D) culture in H14 medium lacking EGF (H14-EGF). Human mammary 
epithelial MCF7 cancer cells (ATCC) of metastatic origin were plated at 8.75 x 105 
cells/cm2 and maintained for 4-6 days in 2D culture in DMEM medium with 10% fetal 
bovine serum.   
Three-dimensional (3D) cell culture of S1 cells was used in some studies for its 
merit of mimicking mammary epithelial differentiation; the detailed procedure was 
followed as described previously (Plachot and Lelievre 2004). Compared to the 
traditional monolayer (2D) cell culture method, in which cells are proliferating on a 
plastic surface,  cells in 3D cultures are surrounded by extracellular matrix-enriched 
medium (Plachot and Lelievre 2004).  To recapitulate the formation of polarized 
glandular structures (acini), S1 cells were cultured in the presence of exogenous 
extracellular matrix (ECM) enriched in basement membrane components (Matrigel™, 
BD Biosciences). Briefly, S1 cells (35,000 cells/cm2) were plated on 41 µl/cm2 matrigel-
coated surfaces and cultured in H14 medium containing 5% Matrigel™. Cells were 
induced to exit the cell cycle upon incubation in H14 medium without EGF for 48 h after 




of epithelial cells surrounding a lumen and delineated by an endogenous basement 
membrane, was routinely observed by days 9–10. Medium was renewed every 2-3 days. 
All cells were cultured at 37°C and with 5% CO2. 
2.2.2.   Actinomycin D treatment 
For actinomycin D treatment experiment, S1 HMECs cultured on coverslips on 
2D, were propagated initially in H14 medium supplemented with additives for 7 days 
followed by an additional 3 days in H14 without EGF to induce growth arrest. Cells were 
then treated with either vehicle Dimethyl Sulfoxide (DMSO) (Sigma-Aldrich) or 0.08 
μg/ml of actinomycin D (Sigma-Aldrich) for 4 hours at 37°C and processed for 
immunofluorescence staining as described in section 2.2.3. 
2.2.3 Immunoflurescence labeling 
Cells cultured on coverslips in 2D were washed in 1X phosphate buffer saline 
(PBS) followed by the permeabilization treatment in 0.5% Triton X-100 (Sigma-Aldrich) 
in cytoskeleton (CSK) buffer [100 mM NaCl (Mallinckrodt); 300 mM sucrose (Sigma-
Aldrich); 10 mM Pipes (Sigma-Aldrich), pH 6.8; 5 mM MgCl2 (Sigma-Aldrich)] 
containing protease inhibitor (CSK-PI). After washing twice for five minutes with CSK-
PI, cells were fixed for 20 minutes at room temperature with 4% formalin (Sigma-
Aldrich). After rinsing thrice for 20 minutes at room temperature with PBS containing 50 
mM glycine (PBS-glycine), cells were incubated for 1 hour at room temperature with 
10% goat serum (Invitrogen Corporation) in immunofluorescence labeling (IF) buffer 
[130 mM NaCl; 13.2 mM Na2HPO4; 3.5 mM NaH2PO4; 0.1% (w/v) bovine serum 




incubated overnight at 4°C with either mouse monoclonal antibody directed against 
NuMA clone B1C11 (kind gift from Dr. Jeffrey Nickerson, University of Massachusetts), 
CENPA, rabbit anti-serum against SMC3, RAD21 (kind gift from Dr. Jan-Michael 
Peters, Research Institute of Molecular Pathology, Vienna, Austria) or rabbit polyclonal 
antibody against NuMA (Abcam), Pol I (Santa Cruz), SMC1 (Bethyl Labs), Ki67 (Vector 
Laboratories). Antibodies were diluted in IF buffer containing 10% goat serum to reach 
the specified concentrations of ½ dilution, 26 μg/ml, 1/50 dilution and 1/50 dilution, 
respectively. Following incubation with the primary antibody, cells were washed thrice 
for 10 minutes with IF buffer, and incubated for 50 minutes at room temperature with 
12.5 μg/ml fluorescein isothiocyanate (FITC)-conjugated donkey anti-rabbit IgG 
(Jackson Immunoresearch) and 6.7 μg/ml Alexa-Fluor 568-conjugated goat anti-mouse 
IgG (InVitrogen Corporation) antibodies diluted in IF buffer containing 10% goat serum. 
After three 10-minute washes with IF buffer, nuclei were counterstained for DNA with 
0.5 μg/ml 4’, 6-diamidino-2-phenylindole dihydrochloride:hydrate (DAPI) (Sigma-
Aldrich) in PBS for 10 minutes. After removal of excess DAPI, samples were mounted 
with ProLong® Gold antifade reagent (Invitrogen Corporation). 
2.2.4   Co-immunoprecipitation (Co-IP) 
S1 HMECs cultured as monolayer (2D) for 12 days in 10 x 150 mm dishes 
(VWR) were processed for co-IP following the protocol provided by the Universal 
Magnetic co-IP Kit (Active Motif). The Co-IP products pulled down by the magnetic 




for 5 minutes to elute proteins from the beads, and subjected to western blot analysis as 
described in 2.2.5 
2.2.5.   Western blot analysis 
Eluted Co-IP products in protein loading buffer or total protein extracts from cell 
cultures prepared in Leammli buffer were loaded on SDS-PAGE gels. The percentage of 
acrylamide was determined by the approximation of protein sample molecular weight. 
5% gel was used to visualize proteins larger than 200 kD; 7.5% gel was used for proteins 
between 40 and 200 kD; and 10% gel was used for proteins smaller than 40 kD. For 
western blot analysis of proteins in Leammli extracts, 30 µg of sample was loaded per 
lane and the target protein was detected with primary antibodies and secondary antibodies 
at the concentrations recommended on the data sheet.  
2.2.6   Chromatin immunoprecipitation followed by quantitative PCR (ChIP-PCR) 
The protocol for ChIP was adapted from that of Dr. Steve Konieczny’s laboratory 
and modified according to a published article (Lee, Johnstone et al. 2006). Specifically, 4 
x 107 T4-2 cells cultured in 150 mm dishes were cross-linked with formaldehyde solution 
(50 mM HEPES-KOH, pH7.5; 100 mM NaCl; 1 mM EDTA; 0.5 mM EGTA; 11% 
formaldehyde) for 10 minutes and quenched with 0.125 M Glycine.  After rinsing three 
times with PBS, cells were harvested by scraping into a 15 ml falcon tube and kept at -
80°C until use.  Dynabeads Protein G (80 µl)  (invitrogen #100.03D) were washed three 
times in 1 ml blocking buffer (PBS with 0.5% bovine serum albumin (BSA) (Sigma; Cat. 




Lab, A301-510A) or IgG at 4°C for 6 hours. Antibody-beads (IgG-beads) were then 
resuspended in 100 µl blocking buffer. Cells were thawed on ice and resuspended in 10 
ml lysis buffer (10 mM Tris-HCl ,pH 7.5; 10 mM NaCl; 3 mM MgCl2; 0.5% IGEPAL; 1 
mM PMSF ( freshly made) by gently pipetting and inverting for 5 minutes, then 
centrifuged at 700 g for 5 minutes. The cell lysis step was repeated twice and cell pellets 
were dissolved in 830 µl pre-IP dilution buffer (10 mM Tris-HCl, pH 7.5; 150 mM NaCl; 
3 mM MgCl2; 1 mM CaCl2; 4% IGEPAL; 0.8% SDS, 1 mM PMSF (freshly prepared); 
protease inhibitor cocktail, Roche (# 11873580001), freshly prepared). The tube was left 
on ice for 5 minutes and the solution was diluted with 3x volumes of IP dilution buffer 
(20 mM Tris-HCl, pH 8; 2 mM EDTA; 1% Triton X-100; 150 mM NaCl; Protease 
Inhibitor cocktail, freshly prepared). Cells in solution were then subjected to sonication 
with for 35 bursts, output 10 watt, with 20 seconds per burst and 90 seconds of pause 
between two bursts in icy water. The sonicated solution was microcentrifuged at 14,000 
rpm for 10 minutes to remove the cell debris, and 50 µl of sample was kept aside as input 
control. The rest of the supernatant was split equally into two parts; each volume was 
incubated with antibody-beads or IgG-beads by rotating at 4°C. After 2 hours of 
incubation, the beads were collected and subjected to washes with 700 µl ChIP wash 
buffer 1 (20 mM Tris-HCl, pH 8; 2 mM EDTA; 1% Triton X-100; 150 mM NaCl; 1 mM 
PMSF, freshly prepared), buffer 2 (20 mM Tris-HCl, pH 8; 2 mM EDTA; 1% Triton X-
100; 0.1% SDS; 500 mM NaCl; 1 mM PMSF, freshly added), and buffer 3 (10 mM Tris-
HCl, pH 8; 1 mM EDTA; 0.25M LiCl; 0.5% IGEPAL; 0.5% Deoxycholate). Each 
washing step was performed by gently inverting the tubes back and forth for 5 minutes at 




700 µl of TE buffer. The collected beads were resuspended with 100 µl of elution buffer 
and incubated at 65°C for 30 minutes. The elution buffer containing cross-linked protein 
and chromatin products was transferred into a new tube. The beads were washed again 
with same volume of elution buffer. Reversion of cross-linking was carried out by 
placing the ChIP products and input sample at 65 °C over-night and all samples were 
treated with RNase A (0.2 µg/ml) for two hours followed by two hours of treatment with 
proteinase K (0.2 µg/ml). At last, the chromatin samples were purified with Qiagen PCR 
Purification Kit and resolved in 50 µl EB. 
The ChIP products were analyzed with real-time PCR on ABI 7300 with Sybr 
green. The PCR program was set up as 55 °C for 2 minutes, 95 °C for 10 minutes, 95 °C 
for 10 seconds, annealing at 58 °C for 1 minute, extension at 72 °C for 10 seconds, and 
40 cycles.  
2.3.   Results 
2.3.1.   NuMA influences the nucleolar architecture 
Overall, aforementioned evidence has suggested a potential relationship between 
NuMA and nucleolar function. Nucleolar morphogenesis encompasses three parts, 
namely active rDNA organization in the middle of nucleolus, the nucleolar-associated 
proteins, and the perinucleolar heterochromatin. Because NuMA is observed associated 
with the nucleolus and it is a structural protein, it might be important to maintain 
nucleolar morphology. To assess nucleolar morphology, a DFC protein Fibrillarin was 
immunolabeled in NuMA-silenced S1 cells (via small interfering RNA) and in control 




a portion of centromere is preferentially associated with the nucleoli in the interphase cell 
nucleus (Haaf and Schmid 1991) and because the centromere contains highly repetitive 
DNA sequences, it becomes part of the perinucleolar heterochromatin. The possible 
change of the perinucleolar heterochromatin organization has been assessed by immuno-
labeling the centromeres with an antibody against CENPA, a unique histone H3 variant 
(Guetg, Lienemann et al. 2010), and we adopted a similar method to evaluate the 
perinucleolar heterochromatin upon NuMA silencing. I found that while the typical 
nucleolar protein, fibrillarin is distributed as discrete small dots in NuMA expressing 
(siNT) control cells, it redistributes into large round foci associated with diffuse staining 
in NuMA silenced (siNuMA) cells as shown in Figure 2.3.1.A.  Because the nucleolar 
regions are dark with DAPI staining of the nucleus, the approximate number of nucleoli 
per cells can be determined by the number of these hollow regions combined with the 
presence of Fibrillarin in these locations in DAPI/Fibrillarin stained cell nuclei.  The 
average number of nucleoli was significantly higher in control cells (2.2 ± 0.1) compared 
to NuMA silenced cells (1.3 ± 0.1) as shown in figure 2.3.1.B. Overall, the average 
number of CENPA associated with each nucleolus is significantly different in control 
cells and in NuMA silenced cells, 5.7 compared to 7.8, which indicates alterations in 
nucleolar morphology based on the number of nucleoli and the reorganization of 
centromeric heterochromatin in the perinucleolar region upon NuMA silencing. 
However, confocal microscopy will be needed to readily determine the exact location of 






    
 
 
Figure 2.3.1.  NuMA silencing influences nucleolar morphology. S1 cells were 
transfected with siRNA against NuMA or scrambled small RNA as control followed by 
the immunostaining for NuMA/Fibrillarin/CENPA in siNuMA cells and 
Fibrillarin/CENPA in siNonTarget transfected cells six days after the transfection (A), 
size bar, 10 µm. More than 30 cell nuclei were randomly selected for each biological 




well as the number of CENPA foci associated each nucleoli (C) in control and NuMA 























2.3.2.   NuMA silencing affects nucleolar function with respect to rRNA transcription 
The alteration of nucleolar morphology upon NuMA silencing gave rise to the 
possibility that NuMA might influence nucleolar functions. The nucleolus is responsible 
for rDNA transcription, rRNA processing, and ribosome assembly and transportation. 
Our previous work has shown that NuMA is possibly involved in ribosomal biogenesis 
(Jayaraman, Ph.D. Thesis, 2014). To re-assess NuMA’s influence on rDNA transcription, 
FUrd assay of nascent rRNA level (Sarshad, Sadeghifar et al. 2013) was performed on S1 
cells transfected with siRNA against NuMA. To eliminate the variation of FUrd signal 
intensity due to different experimental treatments, we decided to compare signal intensity 
in the nucleolar regions between cells with or without NuMA in siNuMA transfected 
cells instead of between siNuMA and siNT transfected cells. Mean fluorescence intensity 
in the nucleolar regions in NuMA expressing cells is about two folds higher than that in 
NuMA silenced cells, which indicates that there is less nascent rRNA in NuMA silenced 
cells as shown in Figure 2.3.2.A & B. Quantitative PCR assay of 45S pre-rRNA, 18S 
rRNA, and 28S rRNA was also performed in NuMA silenced S1 cells and control siNT 
cells. We observed the significant decrease of 28S, 18S, and NuMA RNA level in 
siNuMA transfected cells, but the reduction of 45S pre-rRNA level was not statistically 
significant as shown in Figure 2.3.2.C.  The function of Pol I is essential for rRNA 
production, we thereby assessed the distribution pattern as well as the expression level of 
Pol I in NuMA silenced S1 cells by using immunostaining and western blot assay, 
respectively. Interestingly, we observed that Pol I changed its distribution pattern, which 




compared to more congregate staining in NuMA-expressing cells.  Western blot analysis 
of Pol I did not reveal an apparent change of expression in NuMA silenced cells as shown 
in Figure 2.3.2.E. Given the fact that Pol I binds rDNA on the promoter and coding 
regions, the dispersed distribution of Pol I likely reflects rDNA rearrangement upon 
NuMA silencing. Therefore, it is reasonable to speculate that the decreased level of 28S 
and 18S rRNAs is more likely the consequence of the disruption of rDNA organization 
induced by NuMA silencing than the result of a change in Pol I expression level.  It is 
difficult to assess the localization of NuMA in the nucleolar region using 
immunofluorescence. But upon the inhibition of rDNA transcription mediated by 
actinomycin D, NuMA can be found in distinct perinucleolar regions or caps (Jayaraman, 
S. Ph.D. Thesis, 2014). To assess the localization of NuMA and Pol I, S1 cells were 
subjected to actinomycin D treatement and their locations were analyzed by 
immunofluorescence. As shown in Figure 2.3.2.F, NuMA accumulates in the Pol I-free 
region at the perinucleolus upon actinomycin D treatment, suggesting that NuMA and Pol 
I do not interact when rDNA transcription is inhibited. Interestingly, both NuMA and Pol 
I are both located at the nucleolar periphery, suggesting that they occupy different regions 
















Figure 2.3.2.   NuMA silencing impairs rDNA transcription and disrupts Pol I 
distribution in the nucleolus. 
(A) FUrd incorporation assays in S1 cells subjected to NuMA gene knockdown by RNAi. 
The nucleolar region in NuMA silenced cells are indicated by arrows. Transcription was 
assessed by short FUrd treatment on cells for 20 minutes to allow its incorporation into 
nascent nucleolar transcripts.  
(B) Quantification of the FUrd foci after immunostaining and immunoflurescense 




the recorded images. The signal was quantified using ImageJ software. The average of 
the mean grey values in NuMA expressing (NuMA+) cells was determined, and defined 
as one hundred percent of signal. The average of the mean grey values measured in 
NuMA silenced cells (NuMA-) was expressed proportionally. Each measurement was 
performed on more than 30 cells and three replicates were carried out. Error bars 
represent standard error. * P<0.05. Size bar, 10 µm  
(C) Real-time PCR assay of 45S, 28S, 18S, and NuMA RNA levels was performed on 
siNuMA and control siNT S1 cells as described before. The relative RNA level is shown 
in the bar chart after being normalized to that of the internal reference gene PUM1.  
(D) NuMA (green) and Pol I (red) dual-immunostaining was performed in S1 cells 
transfected with siRNA against NuMA in 2D culture.  Dispersed staining of Pol I in 
NuMA silenced cells is indicated by the arrows. Cell nuclear edges are displayed by 
using function “find edges” in Image J software. Size bar: 10 µm  
(E) Western blot analysis of NuMA and Pol I was performed on cells transfected with 
siNuMA and siNT. Lamin B was used as internal control. Signal intensity relative to 
siNT is labeled under the bands.  
(F) Dual-staining analysis of NuMA and Pol I location in the nucleolus after rDNA 
transcription was inhibited with actinomycin D. Growth-arrested S1 cells on monolayer 
culture were treated with actinomycin D at 0.08 µg/ml to specifically inhibit Pol I 
transcription for 5 hours and subjected to dual-immunostaining for NuMA (green) and 




2.3.3.   NuMA and the cohesin complex interact in interphase 
NuMA has been long considered as a component of the nuclear matrix that 
anchors the genome, but more evidence is still needed to support the original claim of 
NuMA binding chromatin on the matrix attachment regions (MARs) through its S/TPXX 
motifs (Luderus, den Blaauwen et al. 1994). Very interestingly, NuMA interaction with 
the cohesin complex in S phase and M phase of the cell cycle has been reported 
(Gregson, Schmiesing et al. 2001). Thus, it might be possible that NuMA regulates 
chromatin organization through its binding with chromatin-associated complexes like 
cohesin. To further explore this assumption, dual-immunostaining was performed for 
NuMA and cohesin component SMC1 in non-neoplastic S1 cells induced to differentiate 
into acini in 3D cell culture. Acini-like multicellular structures generated under 3D cell 
culture mimic in vivo organization of mammary epithelial cells and importantly, the 
distribution pattern of NuMA in vivo is accurately recaptured in acini produced in 3D 
culture compared to monolayer cell culture on a plastic surface (Lelièvre, Weaver et al. 
1998). Confocal imaging of the dual staining (Figure 2.3.3.A) showed that NuMA and 
cohesin SMC1 are mainly overlapping at the periphery of the nucleolus as well as at the 
periphery of the nucleus.  
    Based on the observation that NuMA and cohesin SMC1 co-localize at the 
perinucleolus and the former result showing NuMA aggregation at the perinucleolus 
upon treatment with nucleolar stress inducer, actinomycin D (Patricia A, M.S. Thesis, 
2003), I tested whether cohesin could form “nucleolar caps” in response to actinomycin 




growth-arrested S1 cells in 2D culture following treatment with actinomycin D at 0.08 
µg/ml for five hours. Both NuMA and cohesin SMC3 were observed to aggregate at the 
perinucleolus to form the “nucleolar cap” structure as shown in Figure 2.3.3.B. The 
scoring results from three replicates (Table 2.3.1) revealed a significantly higher 
percentage of cells simultaneously displaying both NuMA and SMC3 caps upon the 
treatment compared to DMSO-treated control, although NuMA caps and SMC3 caps can 
also be seen to occur independently from each other (i.e., the presence of NuMA caps in 
one nucleolus does not mean that SMC3 caps are also present in that nucleolus and vice 
versa).  
High salt (2M NaCl) removes histones and soluble nuclear proteins to uncover the 
underlying nuclear matrix. Several lines of evidence indicate that NuMA and cohesin 
binding partner CTCF both bind to MARs (Luderus, den Blaauwen et al. 1994; Dunn, 
Zhao et al. 2003; Yusufzai and Felsenfeld 2004). To assess if the insoluble fraction of 
NuMA and cohesin can overlap, monolayer S1 cells were treated with 2M NaCl followed 
by dual-staining for NuMA and cohesin SMC3. Figure 2.3.3.B shows that most of the 
remaining NuMA overlaps with cohesin SMC3 at the edge of the DNA, which suggests 
that NuMA and cohesin might interact at these locations. Interestingly, both DAPI and 
SMC3 immunostaining results revealed a radial meshwork structure in the nucleus after 
NaCl extraction; the NuMA foci located outside of the central dense DNA seem to be 





To investigate whether NuMA could affect cohesin distribution, NuMA-GFP was 
transiently over-expressed in breast cancer cells MCF7 following transfection with 
lipofectmine2000. If NuMA indeed interacts with cohesin, I expected to see an influence 
of NuMA over-expression on cohesin. Immunostaining for SMC3 was performed on the 
NuMA-GFP transfected cells 24 hours post-transfection.  Only GFP was transfected in 



















Figure 2.3.3.   NuMA and cohesin overlap at the perinucleolus. 
(A) Dual-immunostaining for NuMA (red) and cohesin SMC1 (green) in a differentiated 
glandular structure (acinus) shows that NuMA and SMC1 partially overlap at the 
perinucleolus as indicated by arrows. S1 cells in 3D culture were subjected to 
immuostaining on day 12 followed by confocal imaging analysis.  
(B) NuMA (red) and cohesin SMC3 (green) relocalize to the perinucleolus upon 
actinomycin D treatment in non-differentiated (2D culture) growth-arrested cells. S1 cells 
were cultured as 2D monolayer for 10 days and treated with actinomycin D (0.08 µg/ml) 
for 5 hrs to halt rDNA transcription. The nucleolar caps are indicated by arrows. Size bar, 
10 μm. A minimum of 300 nuclei were analyzed in each treatment and the percentage of 
cells displaying NuMA nucleolar caps, SMC3 nucleolar caps, and NuMA/SMC3 double 




(C) The distribution of NuMA and SMC3 after 2M NaCl extraction shows partial overlap 
in the DNA region. Non-neoplastic S1 cells cultured on coverslips were extracted with 
2M NaCl and 0.5% Triton for 15 minutes and subjected to immunostaining for NuMA 
and SMC3 (middle panel) compared to cells without NaCl extraction (upper panel). Size 
bar, 10 μm. NuMA (red) delineates dense chromatin (blue) in the center as well as at the 
periphery of the nucleus; while SMC3 (green) entirely overlaps with the DNA in the 
nucleus. The magnified colocalization of NuMA and SMC3 in one cell from the middle 
right image (indicated by a white rectangle) is shown in the inset.  
(D) Overexpressing NuMA induces aggregation of SMC3 at the perinucleolus in MCF7 
cells. MCF7 cells were transfected with NuMA-GFP (lower panel) or GFP vector (upper 
panel). Immunostaining for SMC3 (red) was performed 24 hours post-transfection. 
Distinctive rings of SMC3 staining surrounding the nucleoli only occurred in NuMA-
GFP over-expressing cells as indicated by arrows in the lower left image but not in GFP 
vector control cells. Size bar, 10 μm 
Table 2.3.3.1.    Percentage of cells displaying nucleolar caps from three replicates 
 NuMA caps (%) SMC3 caps (%) 
NuMA & SMC3 
caps (%) 
Rep-1 ActD 27 27 17.5 
DMSO 7.8 6 1.8 
Rep-2 ActD 18 20 10 
DMSO 3.6 1 0.3 
Rep-3 ActD 31 25 17.5 
DMSO 5.7 4.2 1.5 





2.3.4.   NuMA and cohesin influence chromatin loops 
The partial colocalization of NuMA and cohesin at the periphery of the nucleolus 
and NuMA’s effect on cohesin distribution in the nucleolar region leads to the 
assumption that NuMA might interact with cohesin. To test this hypothesis, co-
immunoprecipitation for NuMA was carried out on growth-arrested S1 cells in 2D culture 
to assess its interaction with cohesin. Our team previously identified ATPase SNF2h as a 
binding partner of NuMA, and others also reported the interaction between cohesin and 
SNF2h (Hakimi, Bochar et al. 2002). Figure 2.3.4.A shows that cohesin components 
RAD21 and SMC3 were pulled down together with NuMA. SNF2h was co-precipitated 
as well.  
One major function of the cohesin complex is to mediate long distance interaction 
in chromatin by generating chromatin loops. Silencing cohesin component like RAD21 or 
SMC3 was reported to increase chromatin loop size that was detected by nuclear halo 
assay (Guillou, Ibarra et al. 2010). The rationale behind the nuclear halo assay is that 
after nuclear soluble proteins are removed by 2M NaCl, the underlying nuclear matrix 
bound by the loosened chromatin is exposed. The unwrapped DNA loops extending out 
of the permeabilized nuclear envelope can be visualized as a halo around the nuclear core 
when a fluorescent DNA dye, like propidium iodide, is applied. To test NuMA’s potential 
involvement in chromatin looping, nuclear halo assay was performed on non-neoplastic 
S1 cells and neoplastic T4-2 cells silenced for NuMA. Both S1 and T4-2 cells showed an 
increased ratio for the diameter of halo/nucleus in siNuMA cells compared to control 




of silencing SNF2h was analyzed in parallel in S1 cells because it interacts with both 
NuMA and cohesin. No significant difference was observed between siNT-cells and 
siSNF2h-cells indicating that SNF2h might not be involved in chromatin looping. Yet, 
the silencing effect of SNF2h in S1 and T4-2 cells needs further validation by both 












                 
               
Figure 2.3.4.   NuMA interacts with cohesin and influences chromatin looping. 
(A) Interaction between NuMA, SNF2h and two components of cohesin (RAD21 and 
SMC3). Nuclear extracts were prepared from growth-arrested non-neoplastic mammary 
epithelial S1 cells and incubated with anti-NuMA antibody or non-specific 
immunoglobulin (IgG) overnight for immunoprecipitation (IP).  Protein K coated 
magnetic beads were used to attract anti-NuMA antibody or IgG. Shown are western blot 
analyses of NuMA, RAD21, SMC3, and SNF2h on anti-NuMA antibody IP fraction 




(B) Comparison of the ratio of halo/nucleus in NuMA silenced S1 and T4-2 cells. S1 (C) 
and T4-2 cells (D) in 2D  culture were treated with trypsin without EDTA on day 6 after 
siRNA transfection and, following detachment from the culture vessels, they were 
incubated in CSK buffer containing 2M NaCl, 0.5% Triton x-100, protease inhibitors, 
and propidium iodide (10 µg/ml) for 3 minutes followed by imaging with a 40x 
microscope lens. Control groups include siNT (NonTarget), and siSNF2h. The diameter 
of the halo and the nuclear core were measured from more than 100 cells with Image J 
under each treatment condition and the ratios of halo/nucleus were compared among 













2.3.5.    NuMA and cohesin are preferentially enriched in specific regions of rDNA 
Chromatin immunoprecipitation assay (ChIP) can be used to assess whether the 
target protein can bind to a specific region of chromatin. Quantitative PCR assay is used 
to validate the potential enrichment of the target protein on a specific chromatin region. 
To test whether NuMA and cohesin co-occupy the same region of rDNA, ChIP-
quantitative PCR assay was performed to assess the potential enrichment of NuMA and 
cohesin SMC3 on different regions of rDNA. Primers targeting rDNA promoter region 
(pro-1), coding regions including 18S (H4), 5.8S (H8), 28S (H13), and nontranscribed 
IGS regions (H18, H27, H32) were selected for the analysis; their positions are shown in 
the drawing Figure 2.5.A. Because qPCR is a very sensitive technique, I observed large 
variations regarding the number of cycles reaching the signal detection threshold when 
different replicates with ChIP products were subjected to quantification, yet the 
enrichment trends on the tested rDNA regions are fairly similar. To eliminate this type of 
variations, two steps of normalization were carried out in my experiment in order to 
obtain the final relative enrichment fold; i.e. the chromatin amount pulled down by the 
target protein was first normalized to that of control IgG in each region and the obtained 
relative fold enrichment at every region was further normalized to the assigned rDNA 
region H4 to distinguish the potential significance of fold change among these rDNA 
regions. The enrichment fold of DNA fragment in H4 is picked up as the reference 
randomly for the second normalization. In fact, since it is the relative difference of 
different regions that was analyzed in the study, any region could be used as the reference 




(Fig.2.3.5.B) and cohesin SMC3 (Fig. 2.3.5.C) are preferentially enriched in the  
nontranscribed IGS H27 region compared to coding regions H8 and H13 (p<0.05, Table 
2.3.5.1 & 2.3.5.2). In fact, the enrichment of NuMA at H27 is more apparent since 
statistical significance (p<0.05) was found in all comparisons between H27 and any other 
regions (Table 2.3.5.1). The second highest enrichment region for NuMA is at H32 and 
the T-test showed nearly significance (p=0.07) when compared to H8 and H13. SMC3 
was also found to be more enriched at H32 based on the average enrichment folds, but it 
was not statistically significant. Based on the above observations, an overall conclusion is 















Figure 2.3.5.   ChIP-qPCR assay of NuMA, cohesin SMC3, and Pol I on rDNA in T4-2 
cells shows that NuMA and cohesin SMC3 are preferentially enriched in specific IGS 
regions. 
(A) Schematic diagram of human rDNA linear structure and the primers used in qPCR 




internal transcribed spacers; rectangle: rRNA coding regions; blue line: intergenic spacer; 
black bar: primers.  The ChIP experiments followed by real-time PCR assay of NuMA 
and SMC3 were performed on monolayer culture of breast cancerT4-2 cells to assess the 
potential binding to different regions on the rDNA; IgG was used as nonspecific binding 
control. The enrichment of NuMA and SMC3 at different rDNA regions relative to H4 
was obtained from a two-step of calculation. First, the enrichment of NuMA and SMC3 
at different rDNA regions relative to IgG was obtained by normalizing the input percent 
of NuMA and SMC3 to that of IgG. Second, the relative enrichment at different regions 
from the first step was further normalized to that of region H4. Pol I was used as positive 
control to validate the ChIP assay on rDNA in two out of four replicate experiments. 











Table 2.3.5.1.   T-Test p-value of the relative enrichment of NuMA among tested regions 
on rDNA (p-value has been round off to 2 decimals) 
NuMA pro-1 H4 H8 H13 H18 H27 H32 
pro-1 - 0.04 0.04 0.02 0.90 0.01 0.25 
H4 - - 0.00 0.00 0.44 0.01 0.49 
H8 - - - 0.92 0.36 0.00 0.07 
H13 - - - - 0.37 0.00 0.07 
H18 - - - - - 0.01 0.32 
H27 - - - - - - 0.01 
H32 - - - - - - - 
Table 2.3.5.2   T-Test p-value (round off to 2 decimals) of the relative enrichment of 
SMC3 among tested regions on rDNA 
SMC3 pro-1 H4 H8 H13 H18 H27 H32 
pro-1 - 0.03 0.25 0.82 0.74 0.01 0.27 
H4 - - 0.00 0.00 0.37 0.06 0.71 
H8 - - - 0.18 0.34 0.00 0.14 
H13 - - - - 0.64 0.01 0.23 
H18 - - - - - 0.07 0.42 
H27 - - - - - - 0.51 
H32 - - - - - - - 
Tables 2.3.5.1 & 2.3.5.2 show the p values of T-tests between the two groups of 







2.3.6.    NuMA affects Ki67 distribution 
After unveiling that NuMA impacts both nucleolar morphology and function, I 
have explored whether NuMA can influence cell cycle marker Ki67. Ki67 is expressed in 
all phases of active cells but absent from quiescent cells, which makes it an important 
marker to indicate cell growth in cancer diagnosis in clinical (Scholzen and Gerdes 
2000). Recent studies also showed that Ki67 is involved in rRNA transcription regulation 
(Bullwinkel, Baron-Luhr et al. 2006; Rahmanzadeh, Huttmann et al. 2007). In addition to 
the well-known fact of NuMA stabilizing the spindle poles during mitosis, which is 
essential for the completion of cell division (Silk, Holland et al. 2009), mounting 
evidence also supports the role of nuclear NuMA in cell cycle progression during the 
interphase (Chandramouly, Abad et al. 2007; Endo, Moyori et al. 2013; Vidi, Liu et al. 
2014).  Therefore immunostaining for cell cycle marker Ki67 in NuMA over-expressing 
MCF7 cells was carried out.  NuMA cDNA or GFP-NuMA was transiently expressed in 
MCF7 cells and empty vector or GFP only was transfected in parallel to be used as 
control. Ki67 staining displays distinct distribution patterns at different stage of the cell 
cycle (van Dierendonck, Keijzer et al. 1989), based on which, six patterns (and their 
roughly corresponding stages) were characterized in this study including no staining 
(quiescence), speckles (early G1), speckles & foci (G1), two or more foci (late G1, S, and 
G2), homogenous staining (M), and single spot as shown in the lower panel in Figure 
2.3.6.A. Ki67 staining as a single spot within the enlarged nucleolus has been commonly 
observed in NuMA silenced S1 cells (data not shown) and it is most likely to represent a 




enter G0.  The percentages of cells in each category based on Ki67 patterns were 
compared between the treatment groups and control groups as shown in the bar chart in 
Figure 2.3.6.A.  The percentage of control cells with speckles and speckles & foci is 
significantly higher in control cells than in the treated cells; in contrast, a higher 
percentage of cells with over-expression of NuMA display a single spot of Ki67 staining. 
These observations suggest that NuMA affects Ki67 distribution, when NuMA is over-
expressed. Although levels of cyclins would have to be measured to correlate changes in 
Ki67 distribution with an alteration of the cell cycle, the increased presence of cells with 
a single spot of Ki67 staining might be related to a change in the number of nucleoli that 
has been correlated with cell proliferation activity (i.e., the more nucleoli the higher the 
proliferation activity). But as explained above, the exact stage of the cell cycle in which 
these cells are requires further investigation. We also observed an increased percentage of 
cells without Ki67 staining in NuMA over-expressing cells, which indicates there is an 
increased number of quiescent cells upon over-expression of NuMA. These changes are 
accompanied with a dramatic decrease in the percentage of cells with multiple speckles 
and small foci of Ki67 staining as well as cells with diffused homogenous staining. 
Overall, our observations suggest that an excessive amount of NuMA hinders impairs 





Figure 2.3.6.   NuMA influences Ki67 distribution and expression in MCF7 cells 
The percentage of cells with different Ki67 patterns upon NuMA over-expression (upper 
panel) and the characterized Ki67 distribution staining (lower panel) in MCF7 cancer 
cells.  MCF7 cells cultured in 2D were either transfected with GFP-NuMA or with 
pCMV-NuMA to trigger over-expression of NuMA. Empty vector pCMV and GFP 
transfected cells were used as controls.  Immunostaining for Ki67 was carried out 24 
hours after the transfection. Under each treatment, more than 300 cells were scored and 
the percentages were compared based on the six different distributions of Ki67 as shown 




2.4.   Discussion 
NuMA is a multifunctional protein localized in the cell nucleus beside its 
presence at the mitotic spindle poles. To this date the possible proposed roles for NuMA 
in the cell nucleus are an involvement in the building of a nuclear matrix (Berezney and 
Coffey 1974), apoptosis (Hsu and Yeh 1996), gene transcription control (Harborth, 
Weber et al. 2000), chromatin organization (Abad, Lewis et al. 2007), and DNA repair 
(Vidi, Chandramouly et al. 2012). Cell cycle reentry upon alteration of NuMA 
distribution in reverted malignant mammary epithelial cells, associated with chromatin 
reorganization, was also reported (Chandramouly, Abad et al. 2007), suggesting a link 
between NuMA function in chromatin regulation and biological consequences in cell 
quiescence control. In an effort to elucidate the underlying mechanism of how NuMA 
controls chromatin organization and thus, possibly exerts its influence on the cell cycle, I 
conducted the study presented above on the role of NuMA in the regulation of nucleolar 
architecture and function.  
The nucleolar architecture was assessed upon NuMA silencing based on three 
aspects, such as the number of nucleoli, the distribution of nucleolar proteins Fibrillarin 
and Pol I, and the number of the centromeres as indicated by CENPA staining associated 
with the nucleolus. My results showed that while the number of nucleoli is decreased in 
NuMA silenced cells, the average number of centromeres associated with each nucleolus 
is increased.  The number of nucleoli is positively correlated with the requirement for 
ribosome biogenesis in these cells, which can be exemplified by the extreme case of 




nucleoli in NuMA silenced S1 cells likely reflected the lesser requirement for ribosomes 
in these cells probably due to the global reduction in cellular activities. In support of this 
hypothesis, an overall reduction of rRNAs in NuMA silenced cells was confirmed by 
qPCR assay of individual rRNA species and the FUrd assay of nascent rRNA. 
Interestingly, an overall reduction of nascent mRNA was also observed in the FUrd assay 
(results not shown), suggesting that the influence of NuMA silencing on RNA production 
is global in the nucleus rather than limited to the nucleolus. The increased average 
number of CENPA associated with nucleoli in NuMA silenced cells signifies that more 
centromeres are associated per nucleolus when NuMA is absent, suggesting an impact on 
heterochromatin organization at the nucleolar periphery.  A subset of centromeres are 
routinely observed to associate or reposition to the nucleoli in the interphase of the cell 
cycle from Drosophila (Padeken, Mendiburo et al. 2013) to human cells (Wiblin, Cui et 
al. 2005), but the biological function of such phenomenon is not clear so far.  Linear 
proximity between NORs and the centromeres on human acrocentric chromosomes 
enables these centromeres to associate with the nucleoli, yet it has not been addressed 
whether centromeres on other chromosomes are equally likely to anchor on the surface of 
nucleoli. The newly recruited centromeres can be from two sources: either from those 
acrocentric centromeres that used to be part of other nucleoli, or from any chromosomes 
recruited by chance.  Based on studies from others (Krystosek 1998; Sullivan, Bridger et 
al. 2001), I favor the first explanation. It would suggest a dynamic microenvironment 
favoring chromosome repositioning in the nucleus in the absence of NuMA. Nonetheless, 





 Pol I staining in NuMA silenced cells revealed a less constrained distribution 
pattern of Pol I foci in the enlarged nucleolar region.  Without labeling rDNA, I was not 
able to conclude whether the reorganization of rDNA occurs upon NuMA silencing. Yet, 
the unchanged Pol I level assessed by western blotting and the less constrained Pol I foci 
in NuMA silenced cells leads me to assume that the decrease in rRNA levels that I also 
measured is more likely caused by the rearrangement of rDNA, although we cannot rule 
out an impact on complexes involved in transcription and interacting with NuMA like B-
WICH (Jayaraman S, Ph.D. 2014). Overall, changes in the nucleolus from these three 
angles bring enough evidence to conclude that NuMA influences nucleolar architecture. 
Both FUrd assay and RT-qPCR were performed to test if the levels of rRNAs are 
affected in NuMA silenced cells. Results on nascent RNAs with FUrd revealed that 
rRNA transcription is indeed impaired by NuMA silencing. RT-quantitative PCR results 
showed that only 28S and 18S but not 45S rRNA levels are significantly decreased in 
NuMA silenced cells. The 28S rRNA and the 18S rRNA are produced from the 45S pre-
rRNA after the cleavage of internal transcribed spacer sequences and external transcribed 
spacer sequences (Boisvert, van Koningsbruggen et al. 2007). Thus, our results also tend 
to indicate that the rRNA processing steps are impaired by NuMA silenced cells. 
However, it should be noted that 45S pre-rRNA was largely decreased in two out of three 
biological replicates; thus the lack of statistical significance for the average decrease of 
45S rRNA level is influenced by the one replicate that displayed no change. The possible 
reason for the variation among biological replicates is likely the extremely short life-span 




before being processed. Further investigation of 45S pre-rRNA level is needed to bring a 
definitive conclusion. 
To understand the mechanism by which NuMA controls nucleolar architecture, 
especially rDNA organization, a literature search was conducted in order to find out if 
NuMA has any binding partner functioning in chromatin remodeling. The identified 
interaction between NuMA and the cohesin complex in S phase and M phase of the cell 
cycle (Gregson, Schmiesing et al. 2001) has attracted my interest because cohesin is a 
well-known global player in chromatin organization (Merkenschlager 2010). More 
importantly, a causal relationship between a dysfunctional cohesin and reduction in the 
number of ribosomes has been repeatedly observed in a group of diseases termed 
cohesinopathies (Bose and Gerton 2010). Cohesinopathies are the genetic diseases 
specifically caused by mutated proteins involved in the cohesin network. Since the 
cohesion of sister chromatids is not significantly affected in these diseases, it is usually 
thought that the mutations impair the function of cohesin in chromatin organization and 
transcription control. In light of the published results showing the interaction between 
NuMA and cohesin in S and M phases, I also assessed this interaction in the cell nucleus 
of nonproliferating cells.  The overlap of NuMA and cohesin notably occurred at the 
periphery of the nucleolus and the periphery of nucleus in cells in 3D culture, and in the 
insoluble nuclear features where the proteins remained closed to the DNA after soluble 
proteins were removed by high salt. Thus, NuMA and cohesin preferentially overlap at 
heterochromatin-enriched regions in non-neoplastic differentiated cells. The 




cells cultured in 2D (no acinar differentiation), but because both proteins displayed strong 
fluorescence signal in the nucleus, it was difficult to identify the colocalization pattern 
(Data not shown).  At least a portion of both NuMA and cohesin remains following high 
salt extraction, possibly as constituents of the nuclear matrix.  The merged images of 
remaining NuMA, cohesin SMC3, and DNA in the nuclei after salt extraction show that 
cohesin staining is almost completely overlapping with DNA while NuMA is distributed 
into dispersed foci overlapping with DNA, which suggests NuMA and cohesin might 
only partially share chromatin functions. This is consistent with the observation from 
cells in 3D culture that the overlap of NuMA and cohesin occurs in particular locations in 
the cell nucleus.  Hence, we could assume that although these proteins might work in 
concert under certain circumstances, they also act independently. This hypothesis is 
supported by results with the formation of nucleolar caps upon halting rDNA 
transcription with actinomycin D, showing that the two proteins are not always 
simultaneously involved depending on the cells. 
It is known that NuMA and cohesin both bind Rae-1 at the mitotic spindle pole to 
coordinate the assembly of the mitotic spindle (Wong and Blobel 2008; Kong, Ball et al. 
2009) during metaphase, but the functional interpretation for NuMA and cohesin 
interaction in S phase remains elusive (Gregson, Schmiesing et al. 2001).  To rule out 
other potential chromatin activities mediated by NuMA and cohesin, like DNA 
replication, and merely focus on the transcription control and subsequently quiescence 
maintenance, co-IP for NuMA and cohesin was performed exclusively in the nucleus of 




pulled down by NuMA together with SNF2h.  As mentioned above, SNF2h is an ATPase 
associated with NuMA (Vidi, Liu et al. 2014), but it is also needed for loading cohesin on 
the chromosomes by the nucleosome remodeling and deacetylase (NuRD) complex 
(Hakimi, Bochar et al. 2002).  NuRD contains HADC1/HADC2 enzymes that are 
important to initiate heterochromatinization (Allen, Wade et al. 2013). Thus, it seems 
logical to observe cohesin appearing in the perinucleolar heterochromatin region given 
that it works together with NuRD. Unfortunately, the reciprocal IP for cohesin 
components failed to bring down NuMA (data not shown). A technical explanation 
would be that the antibody used to IP cohesin disrupted the interaction. Based on the 
study of NuMA and cohesin in metaphase, their interaction seemed to be mediated by 
Rae-1 but it was never addressed whether NuMA and cohesin interact directly (Wong 
and Blobel 2008). If their interaction were indirect, distinct affinities of NuMA and 
cohesin for a third protein might complicate the coimmunoprecipitation results. 
Nevertherless, based on current knowledge, several scenarios could be proposed for the 
interaction between NuMA and cohesin.  It is possible that NuMA and cohesin interact 
through their binding to the same region of chromatin. Published work indicates that 
NuMA and cohesin bind MARs(Luderus, den Blaauwen et al. 1994).  A DNAse 
treatment prior to co-IP would degrade DNA not embedded in the nuclear matrix and 
disrupt the association between NuMA and cohesin at these locations, hence the proteins 
would not co-PI anymore; however, their potential interactions as part of nuclear matrix 
through MARs could still remain and the two proteins would still co-IP, but possibly to a 




protein independently of DNA binding. In this case, the treatment with DNAse would not 
influence the IP result.  
The timing of NuMA and cohesin in their interaction with chromatin also points 
out to complementary yet independent functions. The binding between cohesin and 
chromatin at different phases of the cell cycle is relatively well characterized compared to 
that of NuMA. Cohesin is loaded on chromatin in telophase in metazoans. The binding of 
cohesin to chromatin in G1 phase is believed to be dynamic rather than “stable” due to 
the observation that it takes shorter time for the nearly whole population of cohesin to 
dissociate from chromatin upon photobleaching compared to the time necessary in other 
phases of the cell cycle (Gerlich, Koch et al. 2006). NuMA enters cell nucleus in 
telophase as well and at least a fraction of NuMA associates with chromatin. The 
interaction between NuMA and cohesin in G0/G1 phase was observed in my present 
study. Work from others also indicates a possibility of NuMA and cohesin co-occupying 
the same chromosomal regulatory elements to regulate gene transcription (please see 
Chapter 4 final discussion) (Tarallo, Bamundo et al. 2011) (Tarallo, Bamundo et al. 
2011).   
Distinct recovery times within the cohesin population upon photobleaching after 
G1 phase has raised the hypothesis that cohesin is likely present in different pools 
committed to different functions in S and G2 phases. It is now generally accepted that the 
dynamic cohesin-chromosome binding is mainly responsible for gene transcription 
regulation by mediating intrachromosomal interactions. Stable cohesin-chromosome 




Koch et al. 2006; Jeppsson, Kanno et al. 2014).  NuMA and cohesin interaction in S 
phase has been reported to occur in a small population of both proteins (Gregson, 
Schmiesing et al. 2001); however, it has not been addressed under which circumstance 
the interaction takes place. Given the fact that both NuMA and cohesin are also involved 
in DNA repair, it would not be surprising to see their interaction occur in a specific pool 
either for transcription regulation or for DNA repair.  The release of cohesin from 
chromosomes and NuMA from the nucleus occurs in prophase. NuMA is likely relocated 
to the spindle pole area by the end of prophase, while most cohesin detaches from 
chromosomal arms by the end of metaphase except for centromeric cohesin that is 
removed at the beginning of anaphase and thus, allows the segregation of sister 
chromatids (Horsfield, Print et al. 2012).  These findings tend to indicate that the 
interaction between NuMA and cohesin is likely involved in the pool of cohesin that 
detaches from the chromosomes early on instead of those after the prophase. In addition, 
a small amount of cohesin accumulates at the spindle poles, hence interacting with 
NuMA during mitosis; but the biochemical specificities of these cohesin complexes have 
not been characterized yet, so we cannot rule out the possibility that this fraction of 
cohesin also represents a different pool in the interphase nucleus. 
To my best knowledge, we are the first laboratory to show that both NuMA and 
cohesin form “nucleolar cap” structures upon Pol I inhibition induced by actinomycin D. 
The formation of nucleolar caps usually coincides with nucleolar stress, like that induced 
by the blockage of the ribosome biogenesis network, the inhibition of mRNA 




biological functions of these cap structures are not known currently. Interestingly, 
different proteins were observed to form nucleolar caps depending on distinct stresses, 
hence indicating a specificity of the stress reaction (Malekkou, Lederer et al. 2010). In 
this sense, NuMA and cohesin are functionally-related in the stress reaction upon rRNA 
transcription blockage. Among cells forming caps, over 50% show the simultaneous 
presence of NuMA and cohesin caps around the nucleoli while other cells only contain 
nucleolar caps formed by either NuMA or cohesin, indicating that NuMA and cohesin 
might behave independently from each other. This idea is supported by the fact that the 
cohesin cap can still form in NuMA silenced cells upon actinomycin D treatment (data 
not shown). Another interesting observation is that NuMA aggregates at the periphery of 
the nucleolus without any overlap with caps formed by Pol I (Figure 2.3.2.F) after the 
treatment with actinomycin D.  Under such condition, the formerly active rDNA arrays in 
the interior of the nucleolus compact and reposition to the nucleolar edge, where they are 
flanked by the perinuclolar heterochromatin including silent rDNAs, neighboring 
proximal and distal chromosome regions and other heterochromatin (Guetg, Lienemann 
et al. 2010; Floutsakou, Agrawal et al. 2013). Thus, it may be concluded that NuMA 
might exclusively overlap with the perinucleolar heterochromatin after Pol I is inhibited. 
It should be also pointed out that the reaction of NuMA upon nucleolar stress seems to be 
cell-type or cell-cycle dependent. NuMA was not reported to form the nucleolar cap 
structure in some cancer lines used in the study (Shav-Tal, Blechman et al. 2005). Upon 
comparison between non-neoplastic S1 cells and malignant T4-2 cells, I observed that 
NuMA caps in T4-2 cells are less obvious than those in S1 cells. This reaction of NuMA 




cap can be clearly observed only in non-neoplastic cells that exited the cell cycle (Abad, 
P. M.S. Thesis, 2003).   
Cohesin functions in chromatin looping, which is illustrated with the nuclear halo 
assay. Cells with silenced RAD21 or SMC3 produce larger halo size compared to the 
control cells (Guillou, Ibarra et al. 2010). This may be explained by the loss of integrity 
of the nuclear matrix structure, so that it cannot provide enough chromatin anchoring 
points, which leads to the longer chromatin loops reflected by the halo size. Results from 
halo assays performed on NuMA-silenced S1 cells and T4-2 cells showed a significant 
increase in halo size compared to control cells. It is likely that the effect is 
underestimated because of the low transfection efficiency of the HMT-3522 cell series. 
The mechanism by which cohesin mutations induce defects in ribosome 
biogenesis in Cohesinopathies is not clear. Although a claim has been made in a review 
article that cohesin regulates rDNA loops by binding IGS (Xu, Lu et al. 2014), the related 
evidence is not seen yet by the time this thesis is written. A recent study of the budding 
yeast strain with ECO1 mutation, a homolog of human cohesin acetyltransferase ESCO2 
that causes one type of cohesinopathies if mutated, showed that slowed-down sliding of 
cohesin along the rDNA replication forks decreases rDNA transcription efficiency (Lu, 
Lee et al. 2014). However, many mysteries still remain. For example, what is the 
relationship between the cohesin binding sites for rDNA transcription and replication? 
Moreover, the slowed-down rDNA replication as well as on other genomic regions 
should directly lead to prolonged S phase, yet this was not reported in the cells from 




regions of NuMA and cohesin on rDNA. A preferential binding at IGS compared to 
coding regions was revealed for both NuMA and cohesin SMC3 on rDNAs in T4-2 cells 
and the same pattern was recaptured in MCF7 cells (data not shown).  In the statistical 
analysis, a random region (H4) on rDNA was selected as the reference for the secondary 
normalization of the relative fold enrichment at different tested rDNA regions. I found 
that this was a necessary step in the analysis because a similar enrichment trend was seen 
among the biological replicates of ChIP experiments but the enrichment folds varied 
largely from one replicate to another. A chromosome region closed to MYC gene was 
selected as the negative binding control for cohesin based on the literature at first, but I 
soon found out that it is not practical due to the difference in the gene copy number. The 
normal genome contains only two copies of most genes but there are about 400 copies of 
rDNA.  High background was produced even for the IgG binding at rDNA compared to 
other regions. To eliminate the variations of antibody (and IgG) binding efficacy at 
different regions and to eliminate the variations of enrichment folds due to technical 
issues among the biological replicates, two rounds of normalization were carried out at 
each individual region in the final statistical analysis.  
Human rDNA IGS harbors regulatory elements responsible for rDNA 
transcription at its 5’ and 3’ ends adjacent to the transcribed region (seen Figure 1.7.1), 
but for most parts of the DNA segment between the two terminal regions of IGS potential 
functions remain largely unknown. In present study, NuMA was found to preferentially 
bind to region H27 of the IGS, 27kb downstream of the transcription start site. Published 




present in the region spanning from 25kb to 27kb (Gonzalez and Sylvester 1995), which 
might provide a clue of the DNA pattern for NuMA binding. In addition, three tandemly 
arranged A-containing motif “ActcA blocks” are located at 26,866 – 27,125 bp in this 
pyrimidine-enriched region. A repeat element named “butterfly”, due to the pattern 
shown on the sequencing gel, was also assigned at 27,271 – 27,859 bp. Yet, functional 
studies related to these motifs are not available, although it was speculated that the IGS 
fragment containing these putative motifs might contribute to anchoring rDNA at the 
edge of the nucleolus (Kaplan, Murray et al. 1993; Gonzalez and Sylvester 1995).  
My results have shown that NuMA silencing results in rRNA transcription 
inhibition and NuMA preferentially binds IGS H27. It is reasonable to assume that 
NuMA silencing will decrease its presence at rDNA IGS regions. This effect would be 
concomitant with the reduction in rDNA transcription, hence potentially linking NuMA 
binding to H27 and rDNA transcription. However, the question remains of whether 
NuMA is present solely in active rDNA or at both inactive and active rDNA. The ChIP 
assay for Pol I and histone markers specific of active or inactive rDNA in NuMA 
silenced cells, as well as ChIP (NuMA)-reCHIP (markers of interest) assays in cells 
expressing NuMA, might help answer this question.  Although my current ChIP data 
supports the preferential binding of NuMA and cohesin to IGS, it does not prove that 
these proteins are involved in the loop structure in the rDNA. To further test the potential 
loop organization, 3C assay is required.  
At the end of my project, an initial preliminary effort was made to assess the role 




was observed in NuMA silenced S1 cells, cell cycle arrest should be expected in NuMA-
silenced cells. However, it is not that simple. Indeed, others have observed that NuMA 
silencing does not necessarily lead to cell cycle arrest (Endo, Moyori et al. 2013; Vidi, 
Liu et al. 2014). This situation is partially caused by the fact that NuMA is a stable 
protein and it is not easy to completely deplete it from the cells (Silk, Holland et al. 
2009), especially in the rapidly growing cancer cells. Flow cytometry quantification of 
DNA following NuMA silencing with siRNA indicated possibly a cell-type dependent 
effect on the cell cycle (Vidi, Liu et al. 2014).  For example, the percentage of cells in 
G0/G1 phase was slightly increased in mammary epithelial cell lines, MCF7 and S1. But 
it decreased slightly in human osteosarcoma U2Os and remained unchanged in leukemia 
K562 cells. Therefore, in an effort to better understand the relationship between NuMA 
and proliferation control, cancer cells over-expressing NuMA were analyzed in my 
experiments. Based on the staining pattern of Ki67, which is also a nucleolar protein 
during the interphase of the cell cycle, I observed that an increased population of cells 
accumulates in prolonged G1 and probably also in G0 phase, as shown by the lack of 
Ki67 expression in these cells. The rRNA level and ribosome level have not been 
assessed yet in these cells. Future experiments should investigate the expression pattern 
of different cyclins by dual immunostaining with Ki67 to better correlate the observed 
changes in Ki67 distribution and an alteration of the cell cycle. Cyclin E reaches its peak 
as cells enter S phase. Cyclin A and cyclin B elevate to the highest level in G2 and M 
phase, respectively. Nevertheless, overall results suggest that too much or too little 




expression also disrupts nucleolar structure and function via an imbalance of binding at 
IGS.  
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CHAPTER 3: CDS1 IS FUNCTIONALLY INVOLVED IN CELL POLARITY 





Basoapical polarity is a hallmark of functionally differentiated epithelia. The 
formation of apical polarity acting as a tumor suppressor has been reported previously, 
and deregulation of some tight junction proteins contributes to cancer invasiveness as 
well as metastasis (Qiu, Abo et al. 2000; Huang and Muthuswamy 2010). Our laboratory 
previously demonstrated that the integrity of apical polarity is critical for breast epithelial 
cells to remain quiescent and proposed that the existence of apical polarity is a “brake” to 
prevent quiescent cells from reentering the cell cycle (Chandramouly, Abad et al. 2007). 
To identifiy the gene-expression profile related to apical polarity regulation, whole 
genome analysis at the mRNA level was performed in glandular structures (acini) 
produced in 3D culture with and without apical polarity. CDS1 was one of 30 genes 
identified to be significantly down-regulated upon apical polarity disruption (Cardenas 
JM, Ph.D. Thesis, 2012).  
CDS1 is critical for phosphatidic acid metabolism and encodes an enzyme that 
catalyzes the production of CDP-diacylglycerol (CDP-DAG) using cytidine triphosphate 




precursors of phosphatidylinositides including phosphatidylinositol phosphate (PIP), 
phosphatidylinositol biphosphate (PIP2), and phosphatidylinositol triphosphate (PIP3). 
These phophatidylinositides are important molecules involved in multiple signaling 
pathways conducting various functions (Vivanco and Sawyers 2002; Bharill, Ayyadevara 
et al. 2013). In mammals, the oncogenic protein AKT is activated after it directly binds to 
cell membrane-located PIP3, resulting from the conversion of PI(4,5)P2 by Pi3K (Auger, 
Serunian et al. 1989). The transition balance between PIP2 and PIP3 is controlled by the 
antagonistic functions of Pi3K and PTEN, both of which are among the most frequently 
mutated genes in cancer (Watson, Takahashi et al. 2013). Indeed, constitutively elevated 
PIP3 is reported in most cancer cells (Vanhaesebroeck, Leevers et al. 2001) , suggesting a 
critical involvement of the phosphatidylinositide biosynthesis pathway in cancer 
development and progression. Loss-functional mutated cds, the human CDS1 
homologous gene in Drosophila, leads to the decrease of PIP2 level in photoreceptor cells 
in eyes, but this effect is thought to be specifically caused by the eye-cds isoform since it 
was not observed in other cell types (Wu, Niemeyer et al. 1995).  The global impact of 
CDS to the organism is just getting recognized through a recent study in Drosophila. By 
silencing the CDS gene with RNAi, the Huang group reported an increase of lipid storage 
indicated by the level of triacylglycerol (TAG) and a decrease of PIs in Drosophila 
salivary gland cells as well as in the larva (Liu, Wang et al. 2014). The production of PIs 
and TAG in Drosophila is carried out by two different pathways using PAs as common 
precursors and branched thereafter. Loss of CDS function resulted in the blockade of PIs 
synthesis pathway, hence reinforcing the previous observation in eye photoreceptor cells 




Very interestingly, size reduction was observed in the salivary gland cells with silenced 
CDS while the number of cells was not changed, suggesting that the influence of the 
decrease in PI level is mainly on cell growth rather than on cell proliferation. Yet, neither 
cell size nor TAG accumulation was affected by CDS silencing in fat body cells (Liu, 
Wang et al. 2014), indicating that the lipid metabolism pathways regulating cell growth 
are cell-type dependent. 
In contrast to Drosophila, that contains only one CDP-DAG synthase gene, the 
human genome contains two CDS genes, CDS1 and CDS2 sharing 69% identity at the 
amino acid level (Halford, Dulai et al. 1998). In addition, Tam41 has also been reported 
recently to perform the same function as CDS in yeast mitochondria (Tamura, Harada et 
al. 2013), but the role of its homolog in human, Tamm41, is not clear. The investigation 
of the expression profile of CDS1 and CDS2 in mouse embryo and adult tissues shows 
that CDS1 only specifically expresses in brain, eye, and smooth muscle in contrast to 
CDS2, which is more universally expressed in multiple tissues (Volta, Bulfone et al. 
1999; Inglis-Broadgate, Ocaka et al. 2005). The subcellular localization of CDS1 and 
CDS2 is similar; both proteins are exclusively expressed in the cytoplasm and 
concentrated in the endoplasmic reticulum (ER) (Inglis-Broadgate, Ocaka et al. 2005). 
Recent evidence also suggested that CDS1 and CDS2 might use different PA pools as 
substrates distinguished by the acyl chain of the lipid (D'Souza, Kim et al. 2014).  
Studies performed in vertebrate cells have provided more complicated results 
regarding the function of CDS.  Monkey kidney COS-7 cells transfected with CDS1 




(Lykidis, Jackson et al. 1997). Zebrafish mutant with CDS2 loss-of-function displayed 
decreased PIP2 levels that, consequently, caused the failure of vascular morphogenesis 
(Pan, Pham et al. 2012). The defect in angiogenesis in cds2 mutants was recaptured by in 
vitro invasion assays in cell culture of human endothelial cells HUVEC with CDS1 or 
CDS2 silenced by RNAi. Moreover, silencing CDS2 slightly reduced the number of 
endothelial cells in the zebrafish embryo, yet it was not reported whether cell 
proliferation was impaired as well in vitro.  
Collectively, current evidence suggests that loss of CDS function causes PIP2 
reduction, which is likely to hinder cell growth, cell proliferation and even cell invasion 
depending on the cell type. Therefore, in light of the influence of CDS on major aspects 
associated with cancer and our recent discovery that CDS1 might be linked to basoapical 
polarity, an essential feature of breast homeostasis also involved in proliferation and 
invasion control, it is necessary to further characterize CDS1’s influence in the mammary 
epithelium in order to better unravel its potential role in breast cancer initiation and 
progression. 
3.2.    Materials and methods 
3.2.1   Cell culture 
3D drip method for cell culture was described as in Chapter 2.2.1.  
3D embedded method was applied in all the experiments containing invasive 
ductal carcinoma MDA-MB-231 cells. Briefly, a thin layer of MatrigelTM was coated on 




37ºC. Cells were suspended in MatrigelTM containing 10% H14 medium at the density 
830,000/ml for S1 cells (below passage 60) and 415,000/ml for S1 cells at passage 180 
(S1p180), S2 cells, T4-2 cells, and MDA-MB-231 cells. The cells in MatrigelTM were 
incubated at 37ºC for 30 minutes before H14 medium was added to the gel. Regular H14 
medium was used to culture S1 cells and H14 without EGF was used to culture the other 
cells. The culture medium was renewed every 2-3 days. 
3.2.2.   Drug treatments 
MDA-MB-231 cells were incubated with different reagents from day 1 to day 10 
of 3D culture. Reagents used included integrin beta 1 antibody AIIB2, 15 µg/ml; Pi3K 
inhibitor LY294004, 4 µM; mTOR inhibitor rapamycin, 10 nM; DMSO, 0.25% v/v. 
3.2.3 Quantitative RT-PCR 
Quantitative real time polymerase chain reaction (qRT-PCR) was performed by 
monitoring the increase in SYBR Green fluorescence using a 7300 Real-Time PCR 
machine (Applied Biosystems, Austin, TX). Primers for PUM1, CDS1 and CDS2 were 
commercially obtained (SA Bioscience, Frederick, MD). The thermal cycling conditions 
included one cycle at 50°C, a second denaturing step at 95°C, and 40 cycles with three 
steps: 95°C for 15 seconds, 60°C for 60 seconds and 72°C for 10 seconds. Gene 
transcript levels were calculated relative to PUM1 transcripts by the ΔΔCt method 
(Winer, Jung, Shackel, & Williams, 1999). 




Tumor nodules grown within the MatrigelTM were directly imaged with an IX70 
microscope (Olympus). Images were taken for nodules located at different planes within 
the gel layer by progressively adjusting the microscope focus. The edge of each nodule 
was manually delineated on the pictures using Image J software with “free hand 
selections” function. Nodule’s area and circularity were automatically obtained with the 
“measurement” function. The number of protrusions from the nodule core was counted 
manually as well. 
3.3.   Results 
3.2.1.   CDS1 and CDS2 mRNA levels are gradually down-regulated in the HMT-3522 
cancer progression series. 
Our preliminary data have indicated that CDS1 mRNA is down-regulated in non-
neoplastic S1 cells without apical polarity compared to S1 cells with apical polarity. 
Also, CDS1 protein decreases in S1 cells compared to S1-derived invasive T4-2 cells 
(Cardenas JM, Ph.D. Thesis, 2012). These findings suggest that the CDP-DAG 
synthetase 1 is negatively correlated with malignancy. However, since vertebrate animal 
cells contain two CDP-DAG synthetases, functional compensation might occur when one 
is absent. To this end, both CDS1 and CDS2 mRNAs were assessed in the HMT-3522 
cancer progression series by qRT-PCR.  The HMT3522 series (Briand, Petersen et al. 
1987; Nielsen, Madsen et al. 1994; Radisky, Muschler et al. 2002) contains non-
neoplastic S1 cells at low passage (<60), S1-180 cells (high passage number S1 cell line 
that mimics an hyperplasia-like structure in 3D culture), ductal carcinoma in situ 




breast cancer progression. In addition, MDA-MB-231 cells were also assayed as a control 
due to its extremely low CDS1 level identified previously in the laboratory. 
The qRT-PCR results show that both relative CDS1 (Fig. 3.3.1.A) and CDS2 
(Fig. 3.3.1.B) mRNA levels are gradually down-regulated in the HMT-3522 cell series 
when PUM1 is used as the internal reference gene (Lyng, Laenkholm et al. 2008). CDS1 
mRNA is significantly reduced in S1-180 cells and further reduced in S2 and T4-2 cells. 
CDS2 mRNA is significantly reduced in S2 and T4-2 cells but not in S1-180 compared to 
S1 cells. These qRT-PCR results reinforce our previous hypothesis that the CDP-DAG 
synthetases are negatively associated with cancer progression in the HMT-3522 model of 
















Figure 3.3.1 CDS1 and CDS2 mRNA expressions are down-regulated in cell lines 
representing different stages of breast cancer progression. 
Real-time PCR was performed from tumor nodules formed in 3D culture by the HMT-
3522 cancer progression series as well as from MDA-MB-231 cells. S1 represents S1 
cells in lower passages (usual passage range: 53 to 60), and S1-180 means S1 cells used 
in passage numbers between 178 and 187. Cells were cultured embedded in MatrigelTM 
and collected on day 10, followed by RNA isolation and reverse transcription as 
described in materials and methods. The mRNA expression was calculated based on the 
ΔΔCt value, with the results normalized to the average Ct value of the internal control 
PUM1 (n=3). T-test analyses were conducted to assess the difference between S1 and any 







3.3.2.   Re-expressing CDS1 in MDA-MB-231 cells does not affect cell proliferation, but 
it partially rescues basal polarity when combined with the inhibition of the Pi3K pathway. 
Two of the most important features of cancer cell behavior are uncontrolled 
proliferation and the acquisition of invasive potential. After confirming that the decrease 
of CDS1 coincides with cancer progression, I wanted to know whether CDS1 influenced 
cell proliferation and invasion. Cancer cell invasion is illustrated by cells breaking 
through the basement membrane. This is accompanied with loss of basal polarity as 
shown by breaks in the staining or a diffuse cytoplasmic staining of the basal polarity 
marker beta 4 integrin.  I used MDA-MB-231 cells stably transfected with CDS1 cDNA 
or empty vector available in the laboratory. MDA-MB-231 cell line had been chosen for 
CDS1 transfection because it displayed the lowest endogenous CDS1 level among several 
breast cancer cell lines tested previously (Cardenas JM, Ph.D. Thesis, 2012).  Dual-
staining for cell cycle marker Ki67 and beta4 integrin was performed in CDS1 re-
expressing and control vector tumor nodules produced upon 10 days of 3D cell culture. In 
addition, the same dual-staining was performed on CDS1 re-expressing and control 
vector cells that were subjected to several treatments targeting potential signaling 
pathways that might synergize with CDS1 to tame highly aggressive MDA-MB-213 
cells. Indeed it has been shown previously that these cells have to be targeted from 
different angles to readily revert their aggressive phenotype (Wang, Weaver et al. 1998). 
As discussed in the introduction, CDS1 pathway mediates the transition from PAs into 




molecules to activate mTOR (Foster 2009), which is critical for cell survival. CDS1 re-
expressing and control vector cells were incubated with mTOR inhibitor rapamycin 
during the cell culture period (10 days). Second, because CDS1 locates upstream of the 
Pi3K-AKT pathway, CDS1 re-expressing and control cells treated with Pi3K inhibitor 
LY294002 were also investigated. At last, we incubated CDS1 re-expressing and control 
cells with integrin beta1 blocking antibody that inhibits MAPK signaling necessary for 
cell survival (Wang, Weaver et al. 1998).  
ANOVA-Tukey analysis of the percentage of cells expressing Ki67 showed no 
significant differences among any two treatments suggesting that neither re-expressing 
CDS1 alone nor other combinations of CDS1 and reagents have apparent effect on 
forcing MDA-MB-231 cells to quit the cell cycle (Fig. 3.3.2.A). Interestingly, when 
CDS1 re-expression was combined with LY2940004, the inhibitor of Pi3K, basal polarity 
is partially (schematic is shown in Figure 3.3.2.D) (Vidi, Chandramouly et al. 2012) 
restored in a significant number of cells compared to the CDS1-MDA-MB-213 cells 
treated with vehicle DMSO (p<0.05) (Fig. 3.3.2.B).  Beta4-integrin staining at the basal 
cell membrane was notably more continuous in LY treated CDS1 re-expressing cell 
nodules; many of the cell nodules still could not regain full basal polarity defined as a 
complete circle of basal marker around the nodule. Given that LY alone or CDS1 re-
expression alone has no significant effect on the rescue of basal polarity, this result 
indicates that it is the combination of CDS1 and LY that partially restores basal polarity. 
Increased CDS1 mRNA level in CDS1 re-expressing cells compared to control cells was 







Figure 3.3.2.    Assessment of cell cycle activity and basal polarity in MDA-MB-231 
cells transfected with CDS1 or vector control. CDS1 re-expressing cells or cells with 
control vector were plated in MatrigelTM using the embedded method and treated with 




staining for Ki67 to assess cell cycle status (A) or beta4-integrin to assess basal polarity 
(B). One-way ANOVA-Tukey was applied to identify the potential significance for a 
difference between any two treatments. The transcription level of CDS1 in CDS1 re-
expressing cells and control vector cells are shown in (C). C-DMSO: CDS1-DMSO; V-
DMSO: vector-DMSO; C-rap: CDS1-rapamycin; V-rap: vector-rapamycin; C-LY: 
















3.3.3.   CDS1 re-expression combined with LY treatment in MDA-MB-231 cells reduces 
the size and the circularity of the tumor nodules. 
To investigate the role of CDS1 in the invasive phenotype, the percentage of 
tumor nodules with protrusion were assessed. Also, the size and circularity of tumor 
nodules formed in 3D embedded culture were measured in MDA-MB-231 cells stably re-
expressing CDS1 and compared to cells with vector control. Because all the 
measurements were carried out on the images, the area size of tumor nodules was 
represented by the pixels for convenience. An arbitrary length was setup as a standard for 
determination of invasive protrusion and only those protrusions longer than the standard 
were counted as true invasive protrusions. The percentage of tumor nodules with invasive 
protrusion was obtained by comparing the number of tumor nodules containing 
protrusion(s) to the total number of tumor nodules counted.  
The results show that there is no significant difference regarding the percent of 
nodules with invasive protrusions between LY treated and vehicle DMSO treated 
transfected cells as shown in Figure 3.3.3.A., suggesting that the treatments do not 
prevent MDA-MB-231 to grow invasive protrusions. The overall percentage of the 
cellular nodules containing one protrusion is about 4% in CDS1 cDNA-transfected cells 
and 6% in vector control cells. But the percentage of nodules containing more than one 
protrusions is higher in CDS1 re-expressing cells compared to control. Although not 
statistical significance, this trend is repeatedly observed in three independent replicated 
experiments and the comparison of the average percentage of three replicates between 




percentage in A significant decrease of nodule size is observed on day10 CDS1 re-
expressing cells compared to vector control under LY treatment, indicating that higher 
level of CDS1 expression is negatively correlated with nodule size.  The circularity of the 
nodules is significantly decreased when LY is applied compared to control vehicle. This 
suggests that a decrease of Pi3K signaling combined with CDS1 expression might impact 

















Figure 3.3.3 Assessment of invasion capabilities of the MDA-MB-231 cells over-
expressing CDS1. CDS1-MDA-MB-231 and vector control cells were cultured in 3D 
using the embedded method for 10 days with or without Pi3K inhibitor LY294002. 
Tumor nodules were imaged on day 7 and day 10, respectively, to measure protrusions 
(A), size of the nodules on day 7 and day 10 (B and C), and the circularity of the nodules 
on day 7 and day 10 (D and E). Over 100 cell nodules were measured for each condition 
(n = 3). The unit of area is represented by pixels. Circularity indicates the roundness of 








3.4.   Discussion 
The CDS pathway is so far the only mechanism identified that generates 
phosphatidylinositols from phosphatidic acid. Because this pathway involves multiple 
phosphalipid signal molecules, especially phosphatidylinositides, that are pivotal for cell 
proliferation, growth, survival, cell-cell adhesion, molecules trafficking, and cell skeleton 
arrangement (Toker and Cantley 1997), deregulation of CDP-DAG synthetase expression 
is likely to affect cell activities profoundly.  At present, CDS2 is known to control 
angiogenesis during development in zebrafish (Pan, Pham et al. 2012), but the potential 
similar function of its homologs in higher vertebrates still needs to be confirmed and 
other functions might also be discovered. 
Previous work in our laboratory identified CDS1 to be down-regulated upon the 
disruption of apical polarity in non-neoplastic S1 cells and its expression further reduced 
in invasive T4-2 cells (Cardenas JM, Ph.D. Thesis, 2012). To rule out the possibility that 
CDS2 might compensate for the loss of CDS1 function, I investigated CDS1 and CDS2 
mRNA levels in HMT-3522 breast cancer progression cell series. My results show that 
CDS mRNA levels are decreased during cancer progression, which is consistent with the 
previous finding in our laboratory that CDS1 expression decrease is associated with 
estrogen receptor negative (ER-) invasive breast cancer in archival clinical samples 
(Cardenas JM, Ph.D. Thesis, 2012). Especially, to give further details on previously 
obtained results, CDS1 expression was characterized in normal tissue and breast cancer 
with a semi-quantitative immunohistochemistry technique by Cardenas (Cardenas JM, 




statistical analysis identified a significant association between low CDS1 level and 
estrogen receptor negative breast cancer. CDS1 mRNA level and protein level in 
different cancer cell lines were also assessed with qPCR and western blot, respectively. 
In HMT-3522 series mimicking triple negative breast cancer progression, the decrease of 
CDS1 mRNA level was concomitant with cancer progression. CDS1 was decreased 
mostly in a ER negative breast cancer cell line MDA-MB-231, while it was not 
significantly changed in MCF7 and BT20 cancer cell lines. Western blot analysis of 
CDS1 revealed an interesting pattern of doublet bands in specific cell lines. Non-
neoplastic S1 cells showed a strong expression of lower band while their invasive 
counterpart T4-2 cells displayed a strong expression of the upper band of the doublet. 
While MCF7 cell line only showed the lower band of CDS1, the highly invasive cell line 
MDA-MB-231 only showed higher band. Overall, it seems that the expression of CDS1 
in different cell lines is mostly associated with the degree of invasiveness, but more 
evidence should be obtained to support this hypothesis. These preliminary results 
logically led us to investigate the role of CDS1 in cell proliferation control and invasion. 
Over expressing CDS1 in ER(-) invasive breast cancer cell line MDA-MB-231 failed to 
induce actively dividing cells to exit the cell cycle as indicated by Ki67 
immunofluorescence staining, suggesting that CDS1 does not influence proliferation in 
these breast cancer cells.  Ki67 staining in CDS1-re-expressing cells subjected to other 
potentially phenotype-reverting treatments like the inhibition of mTOR or Pi3K pathways 
did not reveal a difference either when compared to the corresponding controls. This 
observation suggests that re-expression of CDS1 is not able to prevent cell from 




although a decrease in cell size has occurred (Liu, Wang et al. 2014), which seems in 
agreement with my result regarding cell cycle activity but it will be important to also 
assess a possible change in cell size in the MDA-MB-213 cells. However, data from 
Drosophila also indicated that CDS function is cell-type dependent, thus we cannot rule 
out the possibility that CDS1 affects the cell cycle in other types of human cancer cells.  
In my present study, Ki67 staining only indicates whether the cells are still in the cell 
cycle, but without analyzing the distribution pattern for Ki67 or analyze the expression of 
cyclins, I cannot determine if a specific phase of the cell cycle is extended.  I have 
observed a decrease of total cell number upon the combined treatments with the Pi3K 
inhibitor and beta1 integrin blocking antibody regardless the re-expression of CDS1 
compared to other treatments, but the percentage of cells positive for Ki67 still remains 
high. This situation could be due to the slow proliferation of these cells without cell cycle 
exit. Flow cytometry-based cell cycle analysis should provide more information about 
CDS1’s potential role in cell cycle control. 
Disruption of the integrity of the basement membrane is the hallmark of cancer 
progression to the invasive stage. This is usually associated with the redistribution of 
basal polarity markers like beta4 integrin. It is important to find out if CDS1 re-
expression alone or rather combined with other drug treatments that are supposed to tame 
breast cancer cells can restore polarity. If so, CDS1 might function in preventing 
invasion.  It should be noted that none of the treatments could fully restore the basal 
polarity in the MDA-MB-213 tumor nodules, but some nodules did display a 




study as partial basal polarity (Vidi, Chandramouly et al. 2012). By re-expressing CDS1 
or inhibiting the Pi3K pathway alone, no significant difference regarding basal polarity 
was found compared to control cells. But when CDS1 re-expression was combined with 
Pi3K pathway inhibition, an improvement of partial basal polarity was observed. This 
might lead to two possibilities including that both Pi3K activation and lack of CDS1 
contribute to cancer invasion via different pathways, or that their effects are additive. We 
will need to assess the potential changes of PIs level or Pi3K activity in MDA-MB-231 
cells after CDS1 re-expression in order to pin down the signaling pathways influenced by 
CDS1 with regards to polarity.  The activation of the ERK pathway induces the 
expression of matrix metalloproteinase-9 (Chung, Lee et al. 2004), which, in turn, 
degrades the basement membrane components and thus, promotes invasion. In human 
endothelial HUVEC cells with silenced CDS1 or CDS2, phosphorylated ERK (pERK) is 
abolished and accordingly, the invasion is alleviated (Pan, Pham et al. 2012). However, in 
our case, pERK level is decreased in CDS1 re-expressing cells compared to control 
vector cells (data not shown), indicating that breast epithelial cells might respond 
differently to changes in CDS1 expression level compared to endothelial cells. The 
decrease of pERK in CDS1-MDA-MB-231 cells might explain the recovery of basal 
polarity if MMP activity is changed by such a decrease. Overall, PI and PA levels should 
be quantified in CDS1 re-expressing cells to narrow down the altered signaling pathways 
so that we can better understand the contributions from the potential signaling pathways 




Several invasiveness-related characteristics including protrusion, area, and 
circularity of the cell nodules were assayed under the combined CDS1 re-expression and 
Pi3K inhibition in order to determine the potential preventive effects of the treatment. 
Our results showed no difference regarding the percentage of nodules with protrusions 
between treatments and control, suggesting that the observed partial restoration of basal 
polarity is not able to prevent cells from penetrating into the extracellular matrix. A 
significant decrease in nodule circularity was found in CDS1 re-expressing cells 
combined with Pi3K inhibition compared to vector control cells treated with Pi3K 
inhibition, suggesting that CDS1 promotes the shape of tumor nodules to be more 
irregular.  With the same overall percentages of nodules containing invasive protrusions 
between treatment and control, a more detailed examination of the number of the 
protrusions on each nodule revealed that CDS1 re-expressing cells made more nodules 
with multiple protrusions, while vector control cells made more nodules with a single 
protrusion. This observation might explain the difference of circularity. In addition, my 
data showed that CDS1 re-expressing nodules are smaller in size compared to control at 
day 10 of culture.  Several factors could influence nodule size in this study. First, CDS1 
expression level was reported to directly determine cell size in Drosophlia (Liu, Wang et 
al. 2014). Second, the existence of basal polarity affects nodule size by protecting the 
cells from treatment with cytotoxic drugs and promoting cell proliferation, which 
eventually increases the size of cellular nodules (Weaver, Lelievre et al. 2002). 
Alternatively, basal polarity generates mechanical force at the periphery of the tumor 
nodule to maintain multiple cells into a tight spheroid structure. At last, cell death is also 




the smaller size is not due to increased cell death or decreased cell size (Liu, Wang et al. 
2014).  
Collectively, we found that CDS1 re-expression when the Pi3K pathway is 
inhibited led to more invasive growth (less circularity) but smaller size for MDA-MB-
231 cell nodules. But the mechanisms underlying these phenotypes need further 
investigation. A logical explanation based on the CDS signaling pathway should be that 
re-expression of CDS1 increases PIs level, which in turn elevates Pi3K-AKT pathway. It 
is known that the disruption of apical polarity (Bakin, Tomlinson et al. 2000) as well as 
the invasive growth (less circularity) are both the consequences of the increased Pi3K 
activity.  Although Pi3K inhibitor was applied to the cells, its effect could be 
compromised by the re-expression of CDS1 and that could be the reason for the 
treatments still displaying the difference between CDS1 re-expressing and vector control 
cells. The correlation of ER- breast cancer at invasive stage and the down-regulation of 
CDS1 seems to indicate that CDS1 upstream molecules (PAs)-mediated pathways play a 
more important role at the invasive stage in this subtype breast cancer, possibly involved 
in the activation of MMPs to further disrupt basal polarity. Thus, the CDS protein could 
play a dual role in basoapical polarity control. Its expression level might have to increase 
to disrupt the apical polarity through producing more PIs, but as soon as the apical 
polarity is impaired, its level quickly decreases to accumulate more PAs to facilitate 
invasion progression.  To this respect, Pi3K-AKT activity and PA mediated pathways 





In the present study, I have focused on the role of CDS1 in invasion-related basal 
polarity. But how CDS1 is correlated with apical polarity still remains unsolved. We have 
initiated a study to look for genes co-expressing with CDS1 in Oncomine database 
(https://www.oncomine.org/). By setting-up the correlation coefficient at greater than 0.7 
(a moderate to strong correlation), I cross-checked the selected genes from different 
datasets. Very interestingly, when the selected genes were arranged by appearing 
frequency, some of the top genes are tight junction and adherens junction proteins, such 
as EPCAM, Claudin 4, E-cadherin, and so on (data not shown). Because co-expressing 
genes are usually considered functionally related, this result supports our hypothesis that 
CDS1 is linked to apical polarity. Investigating these genes expression profile in CDS1 
re-expressing or silenced non-neoplastic cells could bring more information about how 
CDS1 might regulate apical polarity. 
Bibliography 
Auger, K. R., L. A. Serunian, et al. (1989). "PDGF-dependent tyrosine phosphorylation 
stimulates production of novel polyphosphoinositides in intact cells." Cell 57(1): 
167-175. 
Bakin, A. V., A. K. Tomlinson, et al. (2000). "Phosphatidylinositol 3-kinase function is 
required for transforming growth factor beta-mediated epithelial to mesenchymal 
transition and cell migration." J Biol Chem 275(47): 36803-36810. 
Bharill, P., S. Ayyadevara, et al. (2013). "Extreme Depletion of PIP3 Accompanies the 
Increased Life Span and Stress Tolerance of Pi3K-null C. elegans Mutants." Front 
Genet 4: 34. 
Briand, P., O. W. Petersen, et al. (1987). "A new diploid nontumorigenic human breast 
epithelial cell line isolated and propagated in chemically defined medium." In 




Chandramouly, G., P. C. Abad, et al. (2007). "The control of tissue architecture over 
nuclear organization is crucial for epithelial cell fate." J Cell Sci 120(Pt 9): 1596-
1606. 
Chung, T. W., Y. C. Lee, et al. (2004). "Hepatitis B viral HBx induces matrix 
metalloproteinase-9 gene expression through activation of ERK and PI-3K/AKT 
pathways: involvement of invasive potential." FASEB J 18(10): 1123-1125. 
D'Souza, K., Y. J. Kim, et al. (2014). "Distinct Properties of the two isoforms of CDP-
diacylglycerol Synthase." Biochemistry. 
Foster, D. A. (2009). "Phosphatidic acid signaling to mTOR: signals for the survival of 
human cancer cells." Biochim Biophys Acta 1791(9): 949-955. 
Halford, S., K. S. Dulai, et al. (1998). "Isolation and chromosomal localization of two 
human CDP-diacylglycerol synthase (CDS) genes." Genomics 54(1): 140-144. 
Huang, L. and S. K. Muthuswamy (2010). "Polarity protein alterations in carcinoma: a 
focus on emerging roles for polarity regulators." Curr Opin Genet Dev 20(1): 41-
50. 
Inglis-Broadgate, S. L., L. Ocaka, et al. (2005). "Isolation and characterization of murine 
Cds (CDP-diacylglycerol synthase) 1 and 2." Gene 356: 19-31. 
Liu, Y., W. Wang, et al. (2014). "CDP-diacylglycerol synthetase coordinates cell growth 
and fat storage through phosphatidylinositol metabolism and the insulin 
pathway." PLoS Genet 10(3): e1004172. 
Lykidis, A., P. D. Jackson, et al. (1997). "The role of CDP-diacylglycerol synthetase and 
phosphatidylinositol synthase activity levels in the regulation of cellular 
phosphatidylinositol content." J Biol Chem 272(52): 33402-33409. 
Lyng, M. B., A. V. Laenkholm, et al. (2008). "Identification of genes for normalization of 
real-time RT-PCR data in breast carcinomas." BMC Cancer 8: 20. 
Nielsen, K. V., M. W. Madsen, et al. (1994). "In vitro karyotype evolution and 
cytogenetic instability in the non-tumorigenic human breast epithelial cell line 
HMT-3522." Cancer Genet Cytogenet 78(2): 189-199. 
Pan, W., V. N. Pham, et al. (2012). "CDP-diacylglycerol synthetase-controlled 
phosphoinositide availability limits VEGFA signaling and vascular 




Qiu, R. G., A. Abo, et al. (2000). "A human homolog of the C. elegans polarity 
determinant Par-6 links Rac and Cdc42 to PKCzeta signaling and cell 
transformation." Curr Biol 10(12): 697-707. 
Radisky, D., J. Muschler, et al. (2002). "Order and disorder: the role of extracellular 
matrix in epithelial cancer." Cancer Invest 20(1): 139-153. 
Tamura, Y., Y. Harada, et al. (2013). "Tam41 is a CDP-diacylglycerol synthase required 
for cardiolipin biosynthesis in mitochondria." Cell Metab 17(5): 709-718. 
Toker, A. and L. C. Cantley (1997). "Signalling through the lipid products of 
phosphoinositide-3-OH kinase." Nature 387(6634): 673-676. 
Vanhaesebroeck, B., S. J. Leevers, et al. (2001). "Synthesis and function of 3-
phosphorylated inositol lipids." Annu Rev Biochem 70: 535-602. 
Vidi, P. A., G. Chandramouly, et al. (2012). "Interconnected contribution of tissue 
morphogenesis and the nuclear protein NuMA to the DNA damage response." J 
Cell Sci 125(Pt 2): 350-361. 
Vivanco, I. and C. L. Sawyers (2002). "The phosphatidylinositol 3-Kinase AKT pathway 
in human cancer." Nat Rev Cancer 2(7): 489-501. 
Volta, M., A. Bulfone, et al. (1999). "Identification and characterization of CDS2, a 
mammalian homolog of the Drosophila CDP-diacylglycerol synthase gene." 
Genomics 55(1): 68-77. 
Wang, F., V. M. Weaver, et al. (1998). "Reciprocal interactions between beta1-integrin 
and epidermal growth factor receptor in three-dimensional basement membrane 
breast cultures: a different perspective in epithelial biology." Proc Natl Acad Sci 
U S A 95(25): 14821-14826. 
Watson, I. R., K. Takahashi, et al. (2013). "Emerging patterns of somatic mutations in 
cancer." Nat Rev Genet 14(10): 703-718. 
Weaver, V. M., S. Lelievre, et al. (2002). "beta4 integrin-dependent formation of 
polarized three-dimensional architecture confers resistance to apoptosis in normal 
and malignant mammary epithelium." Cancer Cell 2(3): 205-216. 
Wu, L., B. Niemeyer, et al. (1995). "Regulation of PLC-mediated signalling in vivo by 








CHAPTER 4: FINAL DISCUSSION 
Cells are the smallest units in the body to conduct basic biological functions such 
as differentiation, growth, proliferation, aging, and death. All these aspects contain risk to 
initiate cancer if any function cannot be executed appropriately. Therefore, to understand 
the cells is a fundamental prerequisite for cancer prevention.  Lipids, proteins, and 
nucleic acids are the essential materials that compose a cell. These cellular entities further 
assemble into functional complexes at different levels with distinct structures. The 
arrangement of these functional complexes in a spatial and temporal manner forms the 
cell organization.  Since the cell was first described by Robert Hooke in 1665, every 
discovery on cell organization has broadened our knowledge of the cell to a new level. 
This can be best exemplified by the understanding of the double-helix structure of DNA 
in 1953 that opened the epoch of modern molecular genetics.  Indeed, the appropriate cell 
organization is the structural basis to guide cellular homeostasis. In order to understand 
the influence of mammary epithelial cell organization on breast cancer initiation and 
progression, my current research is focused on two proteins, NuMA and CDS1, which are 
respectively related to cell nucleus organization and basoapical polarity. 
Our laboratory previously reported that NuMA organizes higher order chromatin 
(Abad, Lewis et al. 2007) and affects nucleolar transcription (Jayaraman S, Ph.D. 2014). 




through its interaction with cohesin. My results show that silencing NuMA can change 
nucleolar organization and that NuMA and cohesin are preferentially enriched in the 
rDNA IGS region. Preliminary results further indicate a possible role for NuMA in rDNA 
looping regulation,  thereby, the immediate next step is to test the hypothesis that NuMA 
is involved in rDNA loops using 3C-qPCR technique  (Hagege, Klous et al. 2007).  
Transcription termination factor TTF-I generates a rDNA loop by tethering its two 
binding sites flanking the rDNA coding region (Nemeth, Guibert et al. 2008). Yet, 
NuMA and cohesin were not particularly enriched in TTF-I binding sites (Figure 2.3.5 
B&C, region pro-1 and H13) in my study, rather, NuMA/cohesin might control the rDNA 
loops at IGS regions (Figure 2.3.5 B&C, region H27 and H32). If this is the case, 
NuMA/cohesin might interact with MYC protein, which was demonstrated to bind rDNA 
IGS (Shiue, Nematollahi-Mahani et al. 2014). The assessment for the potential interaction 
between NuMA and MYC (or TTF-I) using co-IP should permit the identification of 
NuMA’s binding partner and thus, provides more information about the rDNA looping 
structure. It is highly possible that the size of rDNA loops is not uniform given the fact 
that not all rDNA genes in the nucleolus are active at the same time. Different epigenetic 
statuses on the rDNA chromatin regions might allow the co-existence of several types of 
loops mediated by distinct proteins. To this end, NuMA/cohesin, MYC, and TTF-I might 
co-exist for rDNA looping regulation. 
The redistribution of Pol I indicated by staining of Pol I large subunit RPA194 
was observed in the nucleolus upon NuMA silencing, but it is not clear if this is due to 




also observed a subpopulation of, if not all, RPA194 aggregating at the spindle poles and 
overlapping with NuMA during mitosis (data not shown). According to the existing 
evidence, transcriptionally inactive Pol I disassembles during the mitosis: some subunit 
like RPA43 stay with the NORs during mitosis while other subunits like RPA40, 
RPA194, and RPA16 are dissociated from the chromosomes (Leung, Gerlich et al. 2004; 
Chen, Dundr et al. 2005), but the destination of RPA194 was not reported, and other 
dissociated subunits were not shown to appear at spindle poles based on my literature 
search. Therefore, this observation might be a novel finding and its biological meaning is 
not clear.  Interestingly, RPA194 behaves similarly as cohesin during the mitosis, which 
is also aggregating at the spindle poles where it interacts with NuMA through Rae 1 as 
discussed earlier (Gregson, Schmiesing et al. 2001; Wong and Blobel 2008). Is the 
presence of RPA194 at spindle poles linked to cohesin or NuMA? Is the presence of 
RPA194 at spindle poles critical for theformation of the poles and mitotic progression? Is 
this another mechanism by which the nucleolus controls the cell cycle? All these answers 
are awaited. 
The result of the FUrd assay of nascent RNAs in NuMA silenced cells indicated 
that the absence of NuMA not only reduces rRNA production but also possibly mRNA 
production, which suggests a global role of NuMA in RNA transcription. This is 
consistent with the Lelièvre laboratory earlier results showing that NuMA controls 
chromatin organization in the whole nucleus. The interaction of NuMA and cohesin 
possibly exists genome-wide and is not confined in the nucleolar region. Several results 




binding sites on the chromatin might shed light on this aspect.  First, NuMA was 
identified as one of activated ERα binding partners (Cheng, Chang et al. 2010; Tarallo, 
Bamundo et al. 2011). Second, cohesin and ERα co-occupy at regulatory elements 
(enhancer and promoter) of hundreds of estrogen responsive genes and cohesin binding to 
these regions is independent of CTCF (Fullwood, Liu et al. 2009; Schmidt, Schwalie et 
al. 2010). Collectively, evidence suggests that NuMA and cohesin might coordinate the 
local chromatin conformation of ERα responsive genes upon estrogen stimulation.  This 
hypothesis can be tested by studying the chromatin loop structure at regulatory elements 
and gene transcription of one ERα regulated gene, like MYC (McEwan, Eccles et al. 
2012).  These experiments might also help answer the critical question –of how NuMA 
influences cell quiescence in mammary epithelial cells. 
Finally, with the help of 3C derived high-throughput techniques combined with 
DNA sequencing and big data analysis, the role of NuMA in higher order chromatin 
organization will be eventually unraveled.  
In the light of the established importance of basoapical polarity on cancer 
initiation and progression, CDS1 was studied, especially for its role in basal polarity and 
invasion control.  The results suggested that re-expression of CDS1 promotes the 
integrity of basal polarity but does not prevent the invasive growth in highly invasive 
MDA-MB-231 cells under our experimental conditions.  The signaling pathways 
influenced by CDS1 re-expression were not identified yet as my goal in this study was to 
mainly assess the impact of CDS1 on polarity-related phenotypes. In future steps, 




function, it would be wise to first identify the phospholipid molecules with a significant 
change in expression level upon CDS1 re-expression in MDA-MB-231 cells.   
Based on microarray analysis and CDS1 being related to PI3K pathways, apical 
polarity establishment or maintenance is another feature that CDS1 might influence and 
that might link it with cancer initiation. In order to assess CDS1’s impact on apical 
polarity reproduced in a 3D cell culture system, I have tried to constitutively silence 
CDS1 in HMT-3522 S1 cells with shRNA, yet I could not obtain stably transfected cells 
due to the difficulty of transfecting the non-neoplastic S1 cells in general.  More effort 
will be conducted in the future to generate S1 cells with CDS1 silenced by using other 
methods, like viral infection. 
In summary, I studied the cell architecture with respect to basoapical polarity and 
nuclear organization through CDS1 and NuMA, respectively. My work improved our 
understanding of the cell architecture and cell architecture-controlled activities such as 
proliferation and invasive growth. Especially for the nucleolus, which is essential for 
ribosome biogenesis, nuclear stress perception, and cell cycle regulation, I have shown 
that NuMA influences nucleolar architecture and rDNA transcripition, likely in 
association with altered proliferation. The elevated activity of the nucleolus is necessary 
to promote cancer growth and thus, the nucleolus is a promising drug target for cancer 
intervention (Quin, Devlin et al. 2014). My study of NuMA helps understand more 
mechanisms by which the nucleolar activities are controlled.  My study also suggested 
that CDS1 protects the integrity of the basal polarity and influences the size and 




conducts the regulation of both apical polarity and basal polarity, it plays a unique role in 
cell architecture control. The biological events corresponding to apical polarity and basal 
polarity are cell proliferation control and survival. Thus, CDS1 could link both functions 
on its own, which makes it a potential valuable protein for pharmaceutical purpose.  
At the whole cell organization level, the two aspects, basoapical polarity and 
nuclear organization, are deep down interdependent instead of separated, as earlier 
studies already established the communication between basal polarity and nuclear 
organization (Lelievre and Bissell 1998; Lelievre, Weaver et al. 1998; Vidi, 
Chandramouly et al. 2012), as well as the link between apical polarity and nuclear 
organization (Abad, Lewis et al. 2007; Chandramouly, Abad et al. 2007). Under these 
different circumstances NuMA seems to play a central role to sense and react to the 
signals sent by polarity and to be responsible for the arrangement of nuclear organization 
accordingly. To this sense, NuMA’s behavior fits very well with that of a nuclear stress 
sensor, which just started to emerge from its functions in regulating the nucleolus.   The 
whole picture of the cell organization reflects the complexity but also the beauty of the 
cell - everything is connected!    
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